Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,45721,-0.0358534807449303,0.0137443836792901,-0.0627924727563389,-0.00891448873352168,0.00909453195450089
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,39870,-0.0273122148708725,0.0154999438157884,-0.0576921047498178,0.00306767500807267,0.0780626416009894
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1070.Time spent watching television (TV),48079,-0.0454417211891166,0.0137871871621112,-0.0724646080268545,-0.0184188343513787,0.000981645072393862
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1080.Time spent using computer,39887,-0.034247055092317,0.0142472387773103,-0.0621716430958451,-0.00632246708878888,0.0162316073057027
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1090.Time spent driving,34587,-0.0630896917980247,0.0155210618448852,-0.0935109730139997,-0.0326684105820497,4.81841729423661e-05
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1160.Sleep duration,50668,0.039624235678056,0.0125948418928091,0.0149383455681502,0.0643101257879617,0.00165576987937893
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,16963,-0.0133091383861003,0.0163123045289246,-0.0452812552627925,0.0186629784905919,0.414571283368788
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,16963,0.0178397514872955,0.0159611641237711,-0.0134441301952958,0.0491236331698869,0.263712100097127
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,16963,0.0327463500690673,0.0181948158850077,-0.00291548906554778,0.0684081892036824,0.0719159008149261
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,16963,0.0397012072700534,0.0187039450187636,0.00304147503327688,0.07636093950683,0.0338008840431454
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,16963,0.0742307837460306,0.0190269641431077,0.0369379340255395,0.111523633466522,9.60284423515861e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,16963,0.00723259683116267,0.0406414316992191,-0.0724246092993068,0.0868898029616321,0.858755595686526
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,16963,-0.00918317232964413,0.041813153177889,-0.0911369525583065,0.0727706078990182,0.826166636254609
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,16963,0.00950731303927875,0.0286454323705639,-0.0466377344070265,0.065652360485584,0.739971667656888
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,16963,0.0549236787724202,0.0210544261314925,0.0136570035546949,0.0961903539901455,0.00909793138207701
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,16963,0.0169009948910035,0.0144005500753118,-0.0113240832566076,0.0451260730386145,0.240557599967371
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,16963,0.0165665877437858,0.0208924891898176,-0.0243826910682567,0.0575158665558282,0.427821164972636
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,16963,0.0182314063169827,0.011691214921086,-0.00468337492834579,0.0411461875623113,0.118917862419517
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,16963,0.0293169605639528,0.0150988103301649,-0.000276707683170369,0.0589106288110759,0.0521931828127206
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,16963,0.0203488853303085,0.0223238764466878,-0.0234059125051996,0.0641036831658167,0.362029097428367
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,16963,-0.00828346059953727,0.0210695230685872,-0.0495797258139681,0.0330128046148936,0.694214426298799
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,16963,0.0206473717615171,0.0281342813013131,-0.0344958195890566,0.0757905631120909,0.463028012276383
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,16963,-0.0260809806806664,0.0265633532907449,-0.0781451531305264,0.0259831917691937,0.326192361521723
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,16963,0.0325832686545246,0.0164012019002164,0.000436912930100432,0.0647296243789488,0.0469784826488862
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,16963,0.0347025651211335,0.0155084524837251,0.00430599825303231,0.0650991319892347,0.0252565070111319
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,16963,0.0106331583660067,0.0193758558498379,-0.0273435190996756,0.0486098358316891,0.583160967054691
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,16975,0.0689022707445565,0.0228152847227634,0.0241843126879402,0.113620228801173,0.00253146799145603
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,16975,0.0369542165408645,0.0225943016129942,-0.00733061462060409,0.0812390477023331,0.101951372349545
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,16975,0.0651326765325491,0.0244532701238953,0.0172042670897143,0.113061085975384,0.00773923902396916
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120098.Mobility problems today,16984,0.0869342216861974,0.0266890501364234,0.0346236834188075,0.139244759953587,0.0011269875128956
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120099.Self-care problems today,16984,0.024762570456639,0.041350920110902,-0.056285232960729,0.105810373874007,0.549287814791412
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120100.Problems doing usual activities,16984,0.0748919268778715,0.0255108130876824,0.024890733226014,0.124893120529729,0.00333249500731927
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120101.Pain or discomfort today,16984,0.0269266226626012,0.0227883790722034,-0.0177386003189175,0.0715918456441199,0.237383210087214
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120102.Anxiety or depression today,16984,0.00498985240194375,0.0275714545653067,-0.0490501985460573,0.0590299033499448,0.856386274381412
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,16928,-0.0181142659716472,0.00505889278320108,-0.0280296958267213,-0.00819883611657305,0.000343664191349915
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,16943,-0.000560507011135402,0.0278208141315319,-0.0550893027089379,0.0539682886866671,0.98392631398003
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",16918,0.00420589352946358,0.0285826696108122,-0.0518161389077283,0.0602279259666554,0.883016658818049
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",16954,-0.00839159192558909,0.0226302567344293,-0.0527468951250705,0.0359637112738924,0.710781503494692
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,16953,0.0480445488058816,0.023245592366486,0.00248318776756903,0.0936059098441941,0.0387658993306636
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,16961,0.0127252775056729,0.0297823403842917,-0.0456481096475388,0.0710986646588846,0.669183783583811
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,16915,-0.0214194302094334,0.0301103102844104,-0.0804356383668778,0.037596777948011,0.476867708656602
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,16959,0.037826015738224,0.0301385289967979,-0.0212455010954999,0.096897532571948,0.209470032344258
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,16942,0.0667267794993013,0.0440337912590996,-0.019579451368534,0.153033010367137,0.129701466261711
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,16871,-0.0476849273619689,0.0600385835368723,-0.165360551094238,0.0699906963703008,0.427068044692236
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11813,0.0328673838527381,0.0309667560344998,-0.0278274579748815,0.0935622256803578,0.288540608301183
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45854,0.00518436910775034,0.0305968889853529,-0.0547855333035413,0.0651542715190419,0.86545048187604
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,42794,-0.0126293230868147,0.0186655717584639,-0.0492138437334039,0.0239551975597744,0.49865673121503
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,49195,-0.0132988877771041,0.013068839400947,-0.0389138130029603,0.0123160374487521,0.308871754436046
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47864,-0.0202961796955513,0.0138809662823327,-0.0475028736089233,0.00691051421782071,0.143704213098532
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,49096,0.0651293030259307,0.0137337601949354,0.0382111330438573,0.092047473008004,2.11921491675115e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,46370,0.0652726628121473,0.0141180723411409,0.0376012410235111,0.0929440846007834,3.78625323595439e-06
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X134.Number of self-reported cancers,51103,0.0781293749971768,0.0246059898627638,0.0299016348661598,0.126357115128194,0.00149812988719912
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51104,0.0771835091174723,0.0130710805379757,0.0515641912630399,0.102802826971905,3.55070873576973e-09
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",51104,0.00583100788508907,0.0128792782895716,-0.0194123775624712,0.0310743933326494,0.650735466753819
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,51104,0.131442835876835,0.0128000023996869,0.106354831173449,0.156530840580221,1.02773194135676e-24
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1438.Bread intake,49614,0.0222138294797674,0.0030997345326683,0.0161383497957376,0.0282893091637973,7.80852059216937e-13
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1458.Cereal intake,48501,0.114767047597948,0.0130031087321247,0.0892809544829836,0.140253140712913,1.11895940302777e-18
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1488.Tea intake,49313,0.0152246633864119,0.00297014068313996,0.00940318764745759,0.0210461391253662,2.97225696245678e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1498.Coffee intake,47110,0.0420971557937086,0.0131248507095265,0.0163724484030368,0.0678218631843805,0.00134012036286929
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1528.Water intake,47233,0.0130199720214802,0.0133525711637589,-0.0131510674594874,0.0391910115024477,0.329520115926529
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,34789,-0.11505751602608,0.0153737818823174,-0.145190128515422,-0.0849249035367375,7.37907062802821e-14
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,34779,-0.0980050011495065,0.0157442526431474,-0.128863736330075,-0.0671462659689375,4.87634757746245e-10
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,34874,-0.125940317039176,0.0175234027630422,-0.160286186454738,-0.091594447623613,6.75688695786126e-13
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,34735,-0.0845365908824927,0.0169641449980711,-0.117786315078712,-0.0512868666862733,6.28250169888803e-07
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,34851,0.067404226360806,0.0279808223766731,0.0125618145025268,0.122246638219085,0.0160039206874885
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,38337,0.032539575163023,0.0154672866987881,0.00222369323339842,0.0628554570926477,0.035405231575676
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1807.Father's age at death,37643,0.00462091893756322,0.00341696767842135,-0.00207633771214264,0.0113181755872691,0.176273122354879
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1845.Mother's age,19445,0.00971525492282217,0.00785940981461717,-0.00568918831382748,0.0251196981594718,0.216425061293833
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1873.Number of full brothers,50181,0.0087122053555425,0.0126109146449192,-0.0160051873484991,0.0334295980595841,0.48966525082392
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1883.Number of full sisters,50190,0.0207691551027766,0.0126853771234373,-0.00409418405916047,0.0456324942647136,0.101584162170856
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20015.Sitting height,50704,-0.0163247398618852,0.00390658830273115,-0.0239816529352382,-0.00866782678853214,2.93578538218142e-05
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20016.Fluid intelligence score,16384,-0.00486676850751217,0.0205501803196898,-0.0451451219341041,0.0354115849190797,0.812796576506162
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20018.Prospective memory result,17066,0.0999753128239236,0.0275048250983807,0.0460658556310975,0.15388477001675,0.00027898396515552
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),16175,0.00948883873273214,0.00545348427421039,-0.00119999044472022,0.0201776679101845,0.0818852636278281
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),16155,0.0210332379588081,0.00544769789357483,0.0103557500874014,0.0317107258302147,0.000113391745085929
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,50486,0.0103274188385157,0.00314580281348418,0.00416164532408668,0.0164931923529447,0.00102807641855141
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,44466,-0.00961454143231773,0.00668548964744521,-0.0227181011413104,0.00348901827667489,0.15040683393741
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,43592,-0.0229915095323105,0.0147748894103003,-0.0519502927764991,0.00596727371187818,0.119686683105299
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,43526,0.00728790666275086,0.0197610139798478,-0.0314436807377509,0.0460194940632526,0.712276912603155
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,43565,0.00947703409043095,0.0166804157232165,-0.0232165807270733,0.0421706489079352,0.569933773058604
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,43591,-0.00377306214190325,0.01191513426365,-0.0271267252986572,0.0195806010148507,0.751502118573363
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,43925,0.00431134786368968,0.00862091983801187,-0.0125856550188136,0.0212083507461929,0.617005060800598
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,43811,-0.0267285815776282,0.0108816811801325,-0.0480566766906879,-0.00540048646456852,0.0140417742548074
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,43614,-0.00678859764678282,0.013550233743166,-0.0333470557833883,0.0197698604898226,0.616377259664417
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,43883,-0.000719053619079012,0.00997454343046458,-0.0202691587427896,0.0188310515046316,0.942531507926188
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44027,-0.00180312168087231,0.00749504694427949,-0.0164934136916601,0.0128871703299155,0.809885569956532
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,43761,0.000519113257107613,0.0104271540784648,-0.0199181087366834,0.0209563352508986,0.960294146776549
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46605,0.0200585345575638,0.00767820055439159,0.0050092614709563,0.0351078076441713,0.00899377244256568
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46313,-0.0300779891712322,0.0110216520808646,-0.0516804272497267,-0.00847555109273766,0.00635524228205445
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46168,-0.000846241510625428,0.0239261852743092,-0.0477415646482714,0.0460490816270206,0.971785781129936
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46241,-0.000162569727302899,0.0123229455429093,-0.0243155429914052,0.0239904035367994,0.989474317561292
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46484,0.0101020700285615,0.00873296177582447,-0.00701453505205446,0.0272186751091775,0.247370330353888
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46263,-0.035290009413493,0.015497335107678,-0.065664786224542,-0.00491523260244413,0.0227808412095213
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46230,-0.013465289083973,0.0138430046982292,-0.0405975782925022,0.0136670001245562,0.330700390469565
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46270,-0.00201294110090369,0.0113050191906307,-0.0241707787145399,0.0201448965127325,0.858678761914021
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46319,-0.00591495876752297,0.0129771523641124,-0.0313501774011834,0.0195202598661374,0.648537453330593
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46677,0.00104151829341013,0.00663827819967119,-0.0119695069779454,0.0140525435647657,0.875327610222417
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46380,0.0135855025839612,0.0102651758376365,-0.00653424205780628,0.0337052472257288,0.185690498259105
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,39979,0.0131271206152985,0.0107412561904218,-0.00792574151792827,0.0341799827485253,0.221668874462592
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,39692,0.0198636416960342,0.0426399169271729,-0.0637105954812246,0.103437878873293,0.641328176375567
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,39680,0.010719167408859,0.0435331960483739,-0.0746058968459539,0.096044231663672,0.805505671425472
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,39800,0.00142789456101241,0.012654047096645,-0.0233740377484117,0.0262298268704366,0.910157229997478
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,39714,0.0086824410193254,0.0249442092725041,-0.0402082091547827,0.0575730911934335,0.727786144645387
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,39764,0.04571270565433,0.0181322456169574,0.0101735042450936,0.0812519070635665,0.0117036528878808
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,39712,-0.0260109005610696,0.0214798156132251,-0.0681113391629909,0.0160895380408517,0.225923243008956
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,39713,0.0131937508219961,0.0209246889709029,-0.0278186395609736,0.0542061412049658,0.52834817603335
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,39742,3.14833587178194e-05,0.0158122560953228,-0.0309605385881149,0.0310235053055506,0.998411364512508
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,39760,0.0235298925006917,0.0195168525895589,-0.0147231385748438,0.0617829235762272,0.227971523981587
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,40116,-0.00554907534250977,0.00802184299004846,-0.0212718876030048,0.0101737369179852,0.489101050944658
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,39898,0.0382121048186653,0.0113843060743003,0.0158988649130367,0.0605253447242939,0.000789923118167208
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20127.Neuroticism score,40627,0.0341740502717838,0.0131908040529018,0.00832007432809621,0.0600280262154713,0.00958018031751074
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16384,0.0283976794077911,0.0208437972533286,-0.0124561632087329,0.0692515220243152,0.173089077637204
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,15526,0.00689537963358364,0.00565695531302311,-0.00419225277994167,0.0179830120471089,0.222892847817203
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15526,0.00649123562323054,0.00557936059267959,-0.00444431113842147,0.0174267823848825,0.244670062722735
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20191.Fluid intelligence score,12642,0.00393713381068201,0.0243166877061922,-0.0437235740934548,0.0515978417148188,0.871378708495433
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12643,-0.02632269825504,0.0248012777295531,-0.0749332026049641,0.0222878060948841,0.288553711197473
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,11368,-0.0419666721700985,0.02610086930803,-0.0931243760138373,0.00919103167364022,0.107892590309784
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20255.Spirometry QC measure,38010,0.0246749694496937,0.0168523485776849,-0.00835563376256864,0.0577055726619561,0.1431514622212
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20261.avMSE,11181,-0.00833138909105154,0.00653217679175376,-0.0211344556028889,0.00447167742078584,0.202180647522188
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20262.Myopia diagnosis,11181,0.0752081082072774,0.0311061679958313,0.014240018935448,0.136176197479107,0.0156310918127898
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,29146,-0.0140964745706236,0.00396065070063912,-0.0218593499438763,-0.00633359919737092,0.000372675612630983
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,29209,0.0333741614766092,0.00397246910450619,0.025588122031777,0.0411602009214413,4.61075367798019e-17
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,15941,0.0335851837875563,0.0212064614999992,-0.00797948075244202,0.0751498483275547,0.113276376429052
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,15938,-0.0196808020076289,0.0415640872187097,-0.1011464129563,0.0617848089410421,0.635859444776955
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),15936,0.00871775519786358,0.0517633570777986,-0.0927384246746216,0.110173935070349,0.866258500512578
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),15936,0.0324423012029483,0.0201227195123013,-0.00699822904116221,0.0718828314470589,0.106933349921013
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),15936,-0.077244641036378,0.034835589523932,-0.145522396503285,-0.00896688556947121,0.026609434034996
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,15946,0.0381595052980459,0.0450604018996744,-0.0501588824253158,0.126477893021408,0.397090168956094
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,15946,0.00905761106802292,0.0290090781479509,-0.0478001821019608,0.0659154042380067,0.754867027963117
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,15946,0.00555391003020883,0.032511513426624,-0.0581686562859742,0.0692764763463918,0.864360377851402
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,15946,0.0467157908171427,0.0507058971630962,-0.0526677676225259,0.146099349256811,0.356903162377716
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,15946,0.0302966123427211,0.0592673343639213,-0.0858673630105646,0.146460587696007,0.609228131952704
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,15946,-0.00105732664920852,0.0340827020750556,-0.0678594227163175,0.0657447694179004,0.975252077522834
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,15946,-0.0351452917591078,0.0583917191580436,-0.149593061308873,0.0793024777906578,0.547257067002282
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,15946,-0.0142866408964728,0.0434484041018822,-0.0994455129361619,0.0708722311432162,0.742297168960559
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),15948,-0.00818167651184482,0.0585601532324674,-0.122959576847481,0.106596223823791,0.888887686306667
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),15948,0.0430598508376999,0.0268534268294693,-0.00957286574805998,0.0956925674234598,0.108840999952665
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),15948,-0.0288189110746272,0.0403318005076419,-0.107869240069605,0.0502314179203509,0.474900329950534
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,15950,0.0434102802202748,0.0671561533998425,-0.0882157804434166,0.175036340883966,0.518024417483558
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,18489,-0.0466193309676973,0.0201378563794184,-0.0860895294713573,-0.00714913246403729,0.0206233145361331
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,18489,0.0111959242153626,0.0199558382474383,-0.0279175187496165,0.0503093671803416,0.574780467913062
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,18489,0.00182446617294565,0.0200506997633808,-0.0374749053632807,0.041123837709172,0.927499423491926
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20603.Liking for apples,18489,0.00295054264279966,0.0204015317234042,-0.0370364595350725,0.0429375448206718,0.885009653738467
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,18489,-0.0361025486478507,0.0202986564862373,-0.0758879153608758,0.00368281806517443,0.075326999480528
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,18489,-0.0192431453356353,0.0200175380888497,-0.0584775199897807,0.0199912293185101,0.336406754159084
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20606.Liking for avocados,18489,-0.0640848593965758,0.0202007944896684,-0.103678416596326,-0.0244913021968256,0.00151435780021608
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20607.Liking for bacon,18489,-0.0260554220767674,0.0201893353479089,-0.0656265193586688,0.0135156752051341,0.196874626867521
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,18489,-0.0035029269434108,0.0203659962834771,-0.0434202796590259,0.0364144257722043,0.86344035636667
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20609.Liking for bananas,18489,0.051822048592346,0.0207232840371466,0.0112044118795387,0.0924396853051533,0.012404535592602
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18489,-0.0393802387867697,0.0201836803514147,-0.0789402522755425,0.000179774702003185,0.0510610773201322
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,18489,-0.0383173637121902,0.0201715556534481,-0.0778536127929485,0.00121888536856817,0.0575046057500962
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,18489,-0.016784836071492,0.020341268990149,-0.0566537232921842,0.0230840511492001,0.409290454435839
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,18489,-0.0523335542449797,0.0201477640623451,-0.091823171807176,-0.0128439366827834,0.00939831929053159
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,18489,-0.0312838586872224,0.0200766454773752,-0.0706340838228778,0.00806636644843304,0.119197909985589
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,18489,0.0757275783757361,0.0201614359324088,0.0362111639482148,0.115243992803257,0.000173138938426706
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,18489,-0.0592266568313529,0.0200281730655209,-0.0984818760397737,-0.019971437622932,0.00310872681910453
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,18489,-0.136630754516115,0.0204766446632329,-0.176764978056052,-0.0964965309761786,2.58589921220396e-11
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20618.Liking for black olives,18489,-0.0545291488050548,0.0202393755191789,-0.0941983248226455,-0.0148599727874641,0.00706192620174447
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,18489,-0.0931430189394357,0.0203182195048076,-0.132966729168859,-0.0533193087100128,4.5868945451247e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,18489,-0.0260671580336001,0.0201521366684771,-0.0655653459038151,0.013431029836615,0.195848030786443
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,18489,-0.0301102786959053,0.0202971485320743,-0.0698926898187708,0.00967213242696026,0.137965761726335
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,18489,0.00159287237968429,0.0200812552275916,-0.0377663878663953,0.0409521326257638,0.936777880299864
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,18489,-0.0194451571150431,0.0207449745135846,-0.0601053071616689,0.0212149929315826,0.348594398101301
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,18489,0.0120708953549785,0.0200629841028114,-0.0272525534865317,0.0513943441964888,0.547414492879291
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,18489,0.000777244806628698,0.0202134568831539,-0.038841130684353,0.0403956202976104,0.969327837078021
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),18489,-0.0307925628064188,0.0200155254469262,-0.0700229926823942,0.00843786706955663,0.123959693558534
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,18489,-0.0903257164793034,0.0201220644284435,-0.129764962759053,-0.0508864701995542,7.20284698356261e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,18489,0.0304758153606863,0.0203591969544176,-0.00942821066997231,0.0703798413913449,0.134434665720914
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,18489,0.0419185911084713,0.0201718344092655,0.00238179566631099,0.0814553865506316,0.0377162026333775
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,18489,-0.011951765419715,0.0202812687928202,-0.0517030522536426,0.0277995214142127,0.555666800339968
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20631.Liking for cake,18489,0.120406543368485,0.0202983586626724,0.0806217603896472,0.160191326347323,3.0490884496661e-09
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,18489,0.0496408090541225,0.0200372076523715,0.0103678820554744,0.0889137360527705,0.0132420599896274
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20633.Liking for capers,18489,-0.0819261714036734,0.0200834800940352,-0.121289792387982,-0.0425625504193645,4.5364670418406e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,18489,-0.00444238663289204,0.0204589113449685,-0.0445418528690304,0.0356570796032463,0.828103978805168
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,18489,0.0493024730911874,0.0199256704241332,0.0102481590598864,0.0883567871224884,0.0133579456787291
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,18489,0.0789061133750258,0.0201440667734876,0.0394237424989901,0.118388484251062,8.99469761369995e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20637.Liking for cherries,18489,-0.00533077970241753,0.0211310974467287,-0.0467477306980058,0.0360861712931708,0.800833801863081
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20638.Liking for chicken,18489,-0.0407657877165817,0.0210425271365217,-0.0820091409041642,0.000477565471000897,0.0527233326077817
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,18489,-0.142156216279454,0.0201257722453892,-0.181602729880417,-0.102709702678491,1.68270343906591e-12
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,18489,-0.00725383102860745,0.0202433917963909,-0.0469308789495337,0.0324232168923188,0.720099858067954
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,18489,-0.00257864717557063,0.0324965546018648,-0.0662718941952257,0.0611145998440844,0.936753981926682
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20642.Liking for cod,18489,-0.01721062973251,0.0206204594189355,-0.0576267301936236,0.0232054707286036,0.403932064234364
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,18489,0.0154250601008581,0.0219434636555273,-0.0275841286639753,0.0584342488656915,0.48209854550755
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,18489,0.0280124133446062,0.0204267593007793,-0.0120240348849213,0.0680488615741336,0.170279840040434
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20645.Liking for coriander,18489,-0.0592248427197472,0.020121759841343,-0.0986634920087794,-0.0197861934307149,0.00325113263720134
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,18489,0.0503974017676922,0.0200400611085676,0.0111188819948998,0.0896759215404846,0.011917310836945
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20647.Liking for cream,18489,0.0588334571579078,0.0200683033500966,0.0194995825917184,0.0981673317240971,0.00337568341585175
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20648.Liking for croissant,18489,0.0394856320832647,0.0201499936195503,-8.35541105392856e-06,0.0789796195775833,0.0500592967973601
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,18489,0.00822749222858972,0.0202513237657283,-0.0314651023522377,0.0479200868094172,0.684549407980666
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20650.Liking for curry,18489,-0.10169615158185,0.0202882983119861,-0.141461216273343,-0.0619310868903575,5.42097438146849e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,18489,0.0750169730014458,0.0204394301439991,0.0349556899192075,0.115078256083684,0.00024303494494931
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,18489,0.0503179635250997,0.0201443434451048,0.0108350503726943,0.0898008766775051,0.0125028079766981
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,18489,-0.0211515391424938,0.0207255173216108,-0.0617735530928509,0.0194704748078634,0.307478487145462
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,18489,0.0376198372864263,0.0201182685474573,-0.00181196906659011,0.0770516436394426,0.061508773807915
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20655.Liking for eggs,18489,0.0162491466400993,0.0206573941175424,-0.0242393458302837,0.0567376391104824,0.431525007606346
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,18489,-0.00401534640815332,0.0200439663121525,-0.0433015203799721,0.0352708275636655,0.841227101665518
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,18489,-0.0202036764097301,0.0201173449751563,-0.0596336725610363,0.0192263197415762,0.315251340533817
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,18489,-0.0630032214510199,0.0203396459905043,-0.102868927592408,-0.0231375153096314,0.00195415209310672
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,18489,0.00448950615606491,0.0201149953634224,-0.034935884756243,0.0439148970683728,0.823388542455968
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,18489,-0.016422463757225,0.0214301243282382,-0.0584255074405719,0.0255805799261218,0.443492083617619
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,18489,-0.02574833398444,0.0199256376476155,-0.0648025837737663,0.0133059158048863,0.196296677356318
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,18489,0.0159447824862609,0.0201994094817998,-0.0236460600980667,0.0555356250705884,0.429906653677129
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20663.Liking for fruit,18489,-0.00159255811287834,0.0223550041443521,-0.0454083662358084,0.0422232500100517,0.943207959175117
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20664.Liking for garlic,18489,-0.0558950383334762,0.0203654459583856,-0.095811312411912,-0.0159787642550404,0.00606429110672667
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,18489,-0.0509105721272875,0.0200270696742996,-0.0901636286889147,-0.0116575155656604,0.0110273427696581
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,18489,-0.0802744453920754,0.0201214945154864,-0.119712574642429,-0.0408363161417221,6.64716706772938e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,18489,-0.0138877231572919,0.020032965975801,-0.0531523364698618,0.0253768901552781,0.488165481590839
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,18489,0.090450632212195,0.0203015479268448,0.0506595982755793,0.130241666148811,8.42460254727493e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,18489,-0.0348577144926972,0.0199450568821584,-0.0739500259817278,0.00423459699633332,0.080534880080327
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,18489,-0.221166864191376,0.020087097200324,-0.260537574704011,-0.181796153678741,4.16464600318679e-28
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,18489,-0.00917633266071226,0.0199289406514736,-0.0482370563376005,0.029884391016176,0.64519680441126
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20672.Liking for green olives,18489,-0.0646685926775055,0.0202622187209964,-0.104382541370659,-0.0249546439843525,0.00141731350359719
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20673.Liking for haddock,18489,-0.0280743158096919,0.0205206897415798,-0.0682948677031883,0.0121462360838044,0.171298030657176
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20674.Liking for ham,18489,-0.0234790593510438,0.0201908495275532,-0.063053124425048,0.0160950057229604,0.244902781463903
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,18489,0.00683659152143298,0.0206410769453706,-0.0336199192914934,0.0472931023343594,0.740487414434187
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20676.Liking for herring,18489,0.013492279787154,0.0199685311974535,-0.0256460413598547,0.0526306009341628,0.499254122432243
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20677.Liking for honey,18489,0.0317215699806106,0.0201277997909934,-0.00772891760973642,0.0711720575709577,0.115041130059196
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,18489,-0.0648791763030556,0.020016383600164,-0.104111288159377,-0.0256470644467341,0.00119195261201743
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,18489,0.0473125207042675,0.0202573743803473,0.00760806691878672,0.0870169744897482,0.0195243003316021
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20680.Liking for jam,18489,0.0320702229676278,0.0201658274071774,-0.00745479875043997,0.0715952446856956,0.111778645584397
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,18489,0.00525017528081431,0.0201229361041476,-0.034190779483315,0.0446911300449436,0.794168653934619
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20682.Liking for lager,18489,-0.104385640708512,0.0201610949075706,-0.14390138672735,-0.0648698946896732,2.27142853446028e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20683.Liking for lamb,18489,-0.0216667990983134,0.0202582104381135,-0.0613728915570158,0.0180392933603889,0.284844113693787
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20684.Liking for lemons,18489,-0.0654267933372325,0.0201590357841722,-0.10493850347421,-0.025915083200255,0.00117440205425407
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,18489,-0.0160880480959901,0.0202782542049438,-0.0558334263376798,0.0236573301456997,0.427575650032924
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20686.Liking for liver,18489,0.0126373853361827,0.0202208351831282,-0.0269954516227486,0.0522702222951139,0.531999444865668
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,18489,0.00128633150099871,0.0201067551026031,-0.0381229085001033,0.0406955715021007,0.948990752600986
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,18489,0.111459701702222,0.0200043265472573,0.0722512216695979,0.150668181734847,2.55669833440823e-08
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,18489,-0.00494308470930651,0.0200968563868564,-0.044332923227545,0.0344467538089319,0.805713545675472
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20690.Liking for melon,18489,0.00155551427909155,0.0208229122273997,-0.0392573936866118,0.0423684222447949,0.940452583880579
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,18489,-0.0148073708806494,0.0201885696780412,-0.05437696744961,0.0247622256883113,0.463291377652031
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,18489,0.0193427954438907,0.0206848790684773,-0.0211995675303249,0.0598851584181063,0.349739901097209
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,18489,-0.0157231008777966,0.0201201544597126,-0.0551586036188333,0.0237124018632401,0.434541867283656
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20695.Liking for oranges,18489,0.00259794797574547,0.0204701226484259,-0.0375234924151694,0.0427193883666603,0.899009738262648
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20696.Liking for pasta,18489,0.000481576361352513,0.0204326681671231,-0.0395664532462088,0.0405296059689138,0.981196700996579
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20697.Liking for pears,18489,0.0263613350808149,0.0204970427769702,-0.0138128687620466,0.0665355389236765,0.198422785254436
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20698.Liking for pizza,18489,-0.0192003020473562,0.0201953469268581,-0.058783182023998,0.0203825779292856,0.341754404237395
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,18489,0.0277822443104596,0.0201249178326166,-0.0116625946414689,0.0672270832623882,0.16745258968676
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20700.Liking for plums,18489,0.0296590074477372,0.0203960187026894,-0.0103171892095339,0.0696352041050084,0.145919859638971
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20701.Liking for pollock,18489,-0.0010469845932862,0.020025795558701,-0.0402975438883401,0.0382035747017677,0.958304722284905
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,18489,-0.0150858261642339,0.0201081752402273,-0.0544978496350795,0.0243261973066117,0.453123660219957
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20703.Liking for porridge,18489,0.079221903303194,0.0203824261019355,0.0392723481434003,0.119171458462988,0.000101939819897779
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,18489,-0.0153108955870592,0.0201701758445493,-0.0548444402423759,0.0242226490682575,0.447810877049996
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,18489,-0.00783567183983417,0.0203636027691892,-0.0477483332674449,0.0320769895877766,0.700398854063294
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20706.Liking for prawns,18489,-0.0282543459604494,0.0203379826604608,-0.0681167919749525,0.0116081000540537,0.164776430001312
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,18489,0.0112832618002161,0.0202142708271149,-0.028336709020929,0.0509032326213612,0.576726213449904
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20708.Liking for red meat,18489,-0.0298221969945831,0.0201833616979733,-0.0693815859226108,0.00973719193344466,0.139541725131791
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20709.Liking for red wine,18489,-0.156200979985011,0.0201408333416007,-0.195677013334548,-0.116724946635474,9.25979898306191e-15
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18489,-0.00816188364731753,0.0207536609941603,-0.0488390591958717,0.0325152919012366,0.694121361526402
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,18489,-0.0278100887749756,0.0210254304409641,-0.0690199324392653,0.0133997548893141,0.185955468742445
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,18489,-0.0195311177481196,0.0200716880598941,-0.058871626345512,0.0198093908492727,0.33053224314178
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,18489,-0.0211095485881222,0.0205785653911265,-0.06144353675473,0.0192244395784856,0.304998015311228
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20714.Liking for salami,18489,-0.0284206456068803,0.0200972179850005,-0.0678111928574812,0.0109699016437206,0.157332317232539
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20715.Liking for salmon,18489,0.0120686490286336,0.0210801189935939,-0.0292483841988104,0.0533856822560776,0.566981230801882
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,18489,-0.0394084399509467,0.0200146582153482,-0.0786371700530293,-0.00017970984886418,0.0489704423120294
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,18489,-0.0266632387801011,0.0200907485265682,-0.0660411058921748,0.0127146283319727,0.184478738410893
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20718.Liking for sardines,18489,0.00843109334356988,0.0200753072484292,-0.0309165088633514,0.0477786955504912,0.67450983376693
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),18489,0.00318456412880681,0.0200566367205809,-0.0361264438435318,0.0424955721011455,0.873845068377622
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,18489,0.0107629374830611,0.0203073481783117,-0.0290394649464299,0.0505653399125521,0.596116836791493
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18489,-0.0633700783689837,0.020097184033394,-0.102760559074436,-0.0239795976635314,0.00161759665032499
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,18489,-0.0454258151248582,0.0200534038199001,-0.0847304866118623,-0.00612114363785399,0.023509358603682
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,18489,-0.01195846915818,0.0203146008407438,-0.0517750868060379,0.0278581484896779,0.556094058272594
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,18489,-0.0360320812723316,0.0201769001036357,-0.0755788054754575,0.0035146429307943,0.0741466617816153
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,18489,-0.0562622265427738,0.0201160655853477,-0.0956897150900552,-0.0168347379954924,0.0051652016683745
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,18489,0.0159587567227341,0.0201128174068569,-0.0234623653947055,0.0553798788401736,0.427518884126481
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,18489,-0.109867194305563,0.0202040083812261,-0.149467050732766,-0.0702673378783597,5.4599404677339e-08
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20728.Liking for spinach,18489,-0.00459414718686887,0.0203354807483587,-0.0444516894536519,0.0352633950799142,0.821267849221376
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20729.Liking for spirits,18489,-0.17960853396284,0.0201244433441836,-0.219052442917439,-0.14016462500824,4.87060447610416e-19
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,18489,-0.0148221684769828,0.0219161531736386,-0.0577778286973145,0.0281334917433489,0.49885072465852
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18489,-0.0171173762176279,0.0205296642129108,-0.057355518074933,0.0231207656396772,0.404411557831719
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,18489,0.0711279259562323,0.0201474368152038,0.031638949798433,0.110616902114032,0.000415987574767756
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,18489,-0.0473809561865389,0.0205164814205112,-0.0875932597707409,-0.00716865260233689,0.0209318495320293
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,18489,-0.00675763816288645,0.0244144526839191,-0.0546099654233679,0.041094689097595,0.781945659448474
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,18489,0.0395305521929261,0.0210262860275402,-0.00168096842105266,0.0807420728069049,0.0601164537009289
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,18489,-0.00818720497626329,0.0198604895890374,-0.0471137645707765,0.0307393546182499,0.680171378856978
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,18489,-0.0129370542860794,0.0202260914218812,-0.0525801934729666,0.0267060849008077,0.522426271136144
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),18489,0.00405288669160285,0.0199687427207104,-0.0350858490409895,0.0431916224241952,0.839167332566552
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,18489,0.0146856879131013,0.0220555327699033,-0.0285431563159091,0.0579145321421116,0.505514968482378
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,18489,-0.0584364521524025,0.0200279877169903,-0.0976913080777035,-0.0191815962271016,0.00353003701564837
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20741.Liking for watching television,18489,-0.0294997309301899,0.0202020585304037,-0.0690957656497811,0.0100963037894013,0.144242810957993
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20742.Liking for whisky,18489,-0.110376384837382,0.0207830733431435,-0.151111208589944,-0.069641561084821,1.10361034548852e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20743.Liking for white bread,18489,-0.0110400970921934,0.0200328046869798,-0.0503043942786739,0.028224200094287,0.581571162375957
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20744.Liking for white rice,18489,0.00926864458397874,0.0201220716713591,-0.030170615891885,0.0487079050598425,0.645076116155213
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20745.Liking for white wine,18489,-0.134947700880953,0.0200979240512095,-0.174339632021324,-0.0955557697405823,1.94190521896865e-11
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18489,0.0506661537880951,0.0203499078042327,0.010780334491799,0.0905519730843911,0.012792077527948
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,18489,0.0543081309361879,0.0199436522270143,0.0152185725712399,0.0933976893011358,0.00647374337938606
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,18489,-0.0289502366055637,0.020968775564358,-0.0700490367117053,0.0121485635005779,0.167407762769632
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,18489,-0.0729188934750278,0.0200650141393908,-0.112246321188234,-0.0335914657618219,0.00027967568260105
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21001.Body mass index (BMI),50862,-0.247726180125494,0.0128840976075954,-0.272979011436381,-0.222473348814607,4.28580593992646e-82
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21002.Weight,50902,-0.073618960235132,0.00725420713440139,-0.0878372062185588,-0.0594007142517053,3.55008156720649e-24
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,16946,-0.0168336038818582,0.00537164454066263,-0.027362027181557,-0.00630518058215945,0.00172859095526559
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17664,-0.0207777276440907,0.0216031537445142,-0.0631199089833386,0.0215644536951571,0.336167574793601
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17680,-0.0598061857539114,0.0223429258305174,-0.103598320381725,-0.0160140511260973,0.00744111209062886
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17682,0.00728409553356838,0.0221004619628199,-0.0360328099135586,0.0506010009806954,0.741713541261867
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,17607,0.0322526646593789,0.020549232745822,-0.00802383152243221,0.07252916084119,0.116542177690943
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17585,0.0368407145335672,0.0218506048176176,-0.00598647090896332,0.0796678999760977,0.0918083195715193
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,17596,-0.0272250339470341,0.0220867092129825,-0.0705149840044798,0.0160649161104116,0.217725360487527
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,17472,-0.0378430879041836,0.0219200314979176,-0.0808063496401022,0.00512017383173494,0.0842903342675194
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,17531,-0.00194099273448722,0.0245834652975959,-0.0501245847177752,0.0462425992488008,0.937069149068684
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17691,0.0139052426206512,0.0222470863431412,-0.0296990466119055,0.057509531853208,0.531955122730391
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17681,0.00219426721896196,0.0224371229681573,-0.0417824937986263,0.0461710282365502,0.922095168751576
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,9948,-0.0353403836932601,0.0344420789164696,-0.10284685836954,0.0321660909830203,0.304878105544354
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17687,-0.0353785061460032,0.0241880322764464,-0.0827870494078382,0.0120300371158318,0.143582307517784
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17683,-0.0510053972068894,0.0337293432235043,-0.117114909924958,0.015104115511179,0.130501748340638
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17684,-0.0148761035487087,0.0262008782373241,-0.0662298248938639,0.0364776177964465,0.57019756592842
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17683,-0.111696441875407,0.0651244507355377,-0.23934036531706,0.0159474815662474,0.0863402168971257
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17690,0.0109656484563624,0.0255290745206615,-0.0390713376041342,0.0610026345168589,0.6675386676926
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17686,-0.0963000064572574,0.0255367474331811,-0.146352031426292,-0.0462479814882225,0.000163100565205886
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17287,0.0564619409124221,0.0231301018020313,0.0111269413804407,0.101796940444403,0.014654238328287
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17680,-0.0407432791140858,0.0229030211558501,-0.085633200579552,0.00414664235138037,0.0752655117938197
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17687,-0.0440894910364574,0.0330984100297554,-0.108962374694778,0.0207833926218633,0.182853452374172
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17690,-0.0278146613177383,0.0223639186161584,-0.0716479418054088,0.0160186191699321,0.213615695645649
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17687,0.0400729962042578,0.0223232192152069,-0.00368051345754784,0.0838265058660634,0.072650672299863
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),50598,0.0142894003614267,0.0127486418200791,-0.0106979376059283,0.0392767383287817,0.262354193910217
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,44162,0.0242812815141741,0.00331058624554084,0.0177925324729141,0.0307700305554341,2.26470298807425e-13
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,40981,-0.0902402200392085,0.014452630830442,-0.118567376466875,-0.0619130636115422,4.31077322949384e-10
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22032.IPAQ activity group,40927,-0.0112320201585505,0.0141414831613444,-0.0389493271547854,0.0164852868376845,0.427048455900859
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22033.Summed days activity,42006,-0.0071749135714378,0.00323667097128668,-0.0135187886751597,-0.000831038467715902,0.0266450265348513
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22034.Summed minutes activity,40927,-0.00814292391304886,0.00326013838610581,-0.0145327951498162,-0.00175305267628146,0.0125032635576763
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22037.MET minutes per week for walking,39169,-0.00769030713099611,0.0033169401166325,-0.0141915097595958,-0.0011891045023964,0.0204275897229269
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,40927,-0.00533777487714967,0.00326664365390929,-0.0117403964388119,0.00106484668451253,0.102261457340618
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,40927,-0.0320947749875924,0.0141449298009029,-0.0598188373973622,-0.00437071257782269,0.0232738142210313
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,39169,-0.00631596538124709,0.00332926282613383,-0.0128413205204694,0.000209389757975217,0.0578212647217497
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,43433,-0.0051326075939342,0.00322330567637638,-0.0114502867196319,0.0011850715317635,0.11131498003572
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X22501.Year ended full time education,12440,0.0238572866536814,0.0146115910806004,-0.00478143186429537,0.0524960051716582,0.102543880913183
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,12359,0.0757216677274495,0.0533383335680878,-0.0288214660660026,0.180264801520902,0.15573538828716
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47748,-0.136221710096388,0.0328720376153723,-0.200650903822518,-0.0717925163702584,3.4188807487424e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23098.Weight,50046,-0.0709561896703292,0.00732081916572195,-0.0853049952351442,-0.0566073841055142,3.39800341372009e-22
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23099.Body fat percentage,50017,-0.124191986678256,0.00701520908168318,-0.137941796478355,-0.110442176878157,6.47478826799284e-70
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23100.Whole body fat mass,49965,-0.130178109452065,0.00677135845922672,-0.14344997203215,-0.116906246871981,4.54736033754485e-82
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23101.Whole body fat-free mass,50041,0.00583669491567548,0.00612648740013009,-0.00617122038857949,0.0178446102199305,0.340747492961531
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23102.Whole body water mass,50046,0.00718219443730948,0.00613596810559407,-0.0048443030496549,0.0192086919242739,0.241802520372152
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23104.Body mass index (BMI),50046,-0.245196335402551,0.0129629619463392,-0.270603740817376,-0.219788929987726,1.62328284872684e-79
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23105.Basal metabolic rate,50044,-0.0055935176825938,0.00655489395138392,-0.0184411098273063,0.00725407446211868,0.393477873801136
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23106.Impedance of whole body,50040,-0.0506641278937461,0.00501609054136263,-0.0604956653548168,-0.0408325904326753,5.805554016422e-24
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23107.Impedance of leg (right),50043,-0.0808740639087412,0.00407856496429856,-0.0888680512387664,-0.0728800765787161,3.61930155782365e-87
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23108.Impedance of leg (left),50042,-0.082355530134402,0.00405036766041179,-0.0902942507488091,-0.0744168095199949,1.54637064915661e-91
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23109.Impedance of arm (right),50033,0.0125201136990456,0.00500404900818507,0.00271217764300283,0.0223280497550883,0.0123526774421723
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23110.Impedance of arm (left),50041,0.00811113128011979,0.00500882376094321,-0.00170616329132889,0.0179284258515685,0.10537430960301
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23111.Leg fat percentage (right),50042,-0.202076215386246,0.0084765477496477,-0.218690248975556,-0.185462181796937,6.50242336032805e-125
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23112.Leg fat mass (right),50041,-0.202202240528161,0.00901700339116815,-0.219875567174851,-0.184528913881472,7.99691984948364e-111
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),50040,0.0462687904778101,0.00640821331656895,0.033708692377335,0.0588288885782852,5.26350925999316e-13
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23114.Leg predicted mass (right),50039,0.0470555846491066,0.00643997676279009,0.034433230194038,0.0596779391041752,2.77660370054751e-13
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23115.Leg fat percentage (left),50036,-0.216430799189473,0.00881986911937527,-0.233717742663449,-0.199143855715498,3.44162492852067e-132
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23116.Leg fat mass (left),50036,-0.216152373314154,0.00939939553023339,-0.234575188553412,-0.197729558074897,2.03922670957899e-116
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),50034,0.0397640482032049,0.00669102076621093,0.0266496475014315,0.0528784489049783,2.81876882850812e-09
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23118.Leg predicted mass (left),50033,0.0401628402359893,0.00672521947021348,0.0269814100743709,0.0533442703976077,2.35976264544026e-09
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23119.Arm fat percentage (right),50033,-0.0698281850757606,0.007811278830389,-0.0851382915833231,-0.0545180785681982,4.04268494964824e-19
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23120.Arm fat mass (right),50028,-0.106266532939522,0.0077368725865566,-0.121430803209173,-0.0911022626698715,7.48840961584501e-43
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),50029,-0.0339194038244747,0.00617034601520335,-0.0460132820142732,-0.0218255256346761,3.87828353178176e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23122.Arm predicted mass (right),50028,-0.0343795567566081,0.00617879410065078,-0.0464899931938837,-0.0222691203193326,2.64823121222739e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23123.Arm fat percentage (left),50023,-0.0755073966007666,0.00800269748176735,-0.0911926836650306,-0.0598221095365026,4.06193758681882e-21
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23124.Arm fat mass (left),50022,-0.111830371980802,0.0077183371036181,-0.126958312703893,-0.0967024312577102,1.77712834990861e-47
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),50019,-0.0330291448055105,0.00629062090723867,-0.0453587617836983,-0.0206995278273227,1.52274012289667e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23126.Arm predicted mass (left),50016,-0.033050969202708,0.00631231822011997,-0.0454231129141432,-0.0206788254912729,1.64802536728527e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23127.Trunk fat percentage,50012,-0.0704570418392319,0.0050353369409778,-0.0803263022435484,-0.0605877814349154,2.10062842753518e-44
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23128.Trunk fat mass,50008,-0.087526797658133,0.00553931679781356,-0.0983838585818476,-0.0766697367344184,4.18770273912003e-56
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23129.Trunk fat-free mass,50001,-0.00728202117915985,0.00555486493972607,-0.018169556461023,0.00360551410270326,0.18988852626817
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23130.Trunk predicted mass,49996,-0.00697238376829909,0.00555790018337662,-0.0178658681277173,0.00392110059111908,0.209666323523839
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,29218,-0.168837550310618,0.00388714430869783,-0.176456353155666,-0.161218747465571,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,29218,-0.188753059908741,0.00373059940161084,-0.196065034735898,-0.181441085081584,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",29218,-0.174326265738355,0.00376319411874556,-0.181702126211097,-0.166950405265614,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,29218,-0.178522085187426,0.00376769867475814,-0.185906774589952,-0.1711373957849,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,29218,-0.188415760243791,0.00373478465169152,-0.195735938161107,-0.181095582326476,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,29218,-0.195482080113806,0.00371063310035991,-0.202754920990511,-0.1882092392371,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,29218,0.025098720944095,0.00450511669002095,0.0162686922316539,0.033928749656536,2.55278179054297e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,29218,-0.141706756383169,0.00405523871774644,-0.149655024269952,-0.133758488496386,4.01802297274247e-262
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,29218,-0.144773818454349,0.00408330812530059,-0.152777102379939,-0.13677053452876,1.27525638008612e-269
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,29218,-0.144451199033688,0.00392128346788713,-0.152136914630747,-0.136765483436629,2.05888584644508e-290
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,29218,-0.0706682066025833,0.0039672154352144,-0.0784439488556036,-0.0628924643495631,1.32421951565696e-70
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,29218,-0.141861217459845,0.00398278734920179,-0.14966748066428,-0.134054954255409,4.83328227787203e-272
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,29218,-0.173990999081546,0.00386874218831462,-0.181573733770642,-0.166408264392449,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,29218,-0.197555635027718,0.00369874490015822,-0.204805175032028,-0.190306095023407,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,29218,0.0188586413910142,0.00434580010363677,0.0103408731878861,0.0273764095941422,1.43280304143538e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,29218,-0.166661896640201,0.00391040698287202,-0.17432629432663,-0.158997498953772,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,29218,-0.173797712343347,0.00375196898652737,-0.18115157155694,-0.166443853129753,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,29218,-0.200193566760839,0.00369437235491451,-0.207434536576471,-0.192952596945207,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,29218,0.0274236108210629,0.00449034047058903,0.0186225434987084,0.0362246781434174,1.02643486551804e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,29218,-0.171176060086875,0.00383628091562282,-0.178695170681496,-0.163656949492255,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,29218,-0.181102778207858,0.00381842023838118,-0.188586881875085,-0.173618674540631,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,29218,-0.176917221517556,0.00378077634409632,-0.184327543151985,-0.169506899883128,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,29218,0.0171573966062133,0.00450391971712338,0.00832971396065145,0.0259850792517751,0.000139568961963755
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,29218,-0.173566107990687,0.0037983061504525,-0.181010788045574,-0.1661214279358,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,29218,-0.168395372572171,0.0039303185801415,-0.176098796989248,-0.160691948155094,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,29218,-0.198374757865379,0.00370021095014615,-0.205627171327666,-0.191122344403093,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,29218,0.0158984672550111,0.0044072749479365,0.00726020835705554,0.0245367261529666,0.000309887692404269
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,29218,-0.114703377078372,0.00408350686745685,-0.122707050538588,-0.106699703618157,2.50957065826858e-171
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,29218,-0.17400422203739,0.00381003013935718,-0.18147188111053,-0.16653656296425,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,29218,-0.18818267189203,0.00371038738154366,-0.195455031159855,-0.180910312624204,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,29218,-0.0864818779103597,0.00412243078549812,-0.094561842249936,-0.0784019135707834,5.37742199218202e-97
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,29218,-0.140540649039049,0.00425398635114255,-0.148878462287289,-0.13220283579081,5.04072199932452e-235
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,29218,0.0139556135233628,0.00404293165615665,0.00603146747729571,0.0218797595694298,0.0005575347935031
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,29218,0.179958578125095,0.00449914492144672,0.17114025407906,0.188776902171131,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,29195,-0.119034468490936,0.00403486770453244,-0.126942809191819,-0.111126127790052,1.62368598064105e-188
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,29195,-0.109713094060159,0.00434331276870522,-0.118225987086821,-0.101200201033496,2.75090769484401e-139
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23436.Total Cholines,29195,-0.122849381635815,0.0040673613744565,-0.13082140992975,-0.11487735334188,2.32232220665295e-197
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,29195,-0.11218561976333,0.00409507630103961,-0.120211969313368,-0.104159270213292,3.63694886492051e-163
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,29194,-0.131770891657547,0.00408674138375144,-0.1397809047697,-0.123760878545394,3.74536830431271e-224
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,29218,-0.185023776971825,0.00372099272085589,-0.192316922704702,-0.177730631238947,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,29218,-0.023648328518119,0.0042898065705541,-0.032056349396405,-0.015240307639833,3.56397576982477e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,29218,-0.154683171224354,0.00385054993029065,-0.162230249087724,-0.147136093360984,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,29195,-0.153560033510503,0.00384067026675042,-0.161087747233334,-0.146032319787672,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,29195,0.0376960115752152,0.0042543860989618,0.0293574148212501,0.0460346083291804,8.40757531455249e-19
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,29195,-0.0732231795278674,0.00399967990516635,-0.0810625521419934,-0.0653838069137413,1.89289963259076e-74
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,29195,-0.145091702907713,0.00385185111126903,-0.1526413310858,-0.137542074729625,3.06225151673596e-303
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,29195,-0.142770501252637,0.00387602259637706,-0.150367505541536,-0.135173496963738,2.35269619686448e-290
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,29195,-0.138881623731041,0.00396133858346383,-0.146645847354631,-0.131117400107452,8.45276606077043e-264
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,29195,-0.159088704115985,0.00385378264517842,-0.166642118100535,-0.151535290131436,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,29195,-0.127624866056008,0.00385884598424505,-0.135188204185128,-0.120061527926888,1.61531759277973e-235
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,29195,-0.0606100858198799,0.00411630718186609,-0.0686780478963374,-0.0525421237434223,6.73617824775258e-49
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,29195,0.00339076656332999,0.00405380786557773,-0.00455469685320235,0.0113362299798623,0.402914334611456
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,29195,0.093532142282825,0.00418680108805371,0.0853260121502397,0.10173827241541,1.26285743021003e-109
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,29195,0.100462568943986,0.00426312671405608,0.0921068405844361,0.108818297303536,1.19514241553005e-121
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,29195,-0.064043436128669,0.00435854578027569,-0.0725861858580094,-0.0555006863993287,1.0555366231855e-48
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,29195,-0.0915341857695663,0.00392725239004822,-0.0992316004540608,-0.0838367710850718,4.56965297733122e-119
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,29195,0.0379632715101594,0.00420801358880905,0.0297155648760937,0.0462109781442252,1.96328009314479e-19
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,29195,0.0387268640611296,0.00414374150069976,0.0306051307197581,0.0468485974025012,9.74261223103379e-21
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,29195,0.0849828428959702,0.00434980339533389,0.0764572282411158,0.0935084575508247,1.84019277329192e-84
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,29193,0.0193657521067607,0.00401150412158216,0.0115032040284597,0.0272283001850617,1.38919254391739e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23460.Alanine,29209,0.0271049126923478,0.00393298341128772,0.0193962652062239,0.0348135601784718,5.62518558819525e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23461.Glutamine,29137,0.0647572250709327,0.00389721282989628,0.057118687924336,0.0723957622175295,1.02260158970643e-61
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23462.Glycine,29183,0.0881422899122986,0.00410385241262554,0.0800987391835525,0.0961858406410447,1.53400282595537e-101
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23463.Histidine,29181,0.0251843154051943,0.00388062679216357,0.0175782868925537,0.0327903439178349,8.73546042278649e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),29197,0.0478189396794707,0.00410894453198036,0.0397654083967892,0.0558724709621522,3.10492698300764e-31
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23465.Isoleucine,29212,0.0893381713919494,0.00398275397303118,0.0815319736048083,0.0971443691790905,1.67730106935583e-110
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23466.Leucine,29213,0.0319935324541257,0.00410391650426983,0.0239498561057568,0.0400372088024945,6.60952928862787e-15
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23467.Valine,29197,0.0379589738867619,0.00411924179700066,0.0298852599646406,0.0460326878088832,3.31431812055528e-20
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23468.Phenylalanine,29207,0.102838409998717,0.00388099963275494,0.0952316507185168,0.110445169278916,6.61073092422049e-153
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23469.Tyrosine,29185,0.0794939415553945,0.00397038362777126,0.0717119896449628,0.0872758934658262,1.40371432963171e-88
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23470.Glucose,29164,0.0127374329194367,0.00395387585522204,0.0049878362432015,0.0204870295956719,0.00127658940304795
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23471.Lactate,29164,-0.0451236725879548,0.00391015839965135,-0.0527875830512714,-0.0374597621246382,9.65953842646411e-31
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23472.Pyruvate,29137,-0.00287947948455568,0.00390969488301686,-0.0105424814552687,0.00478352248615737,0.461434079951129
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23473.Citrate,29214,0.0222085282648372,0.00395684191053451,0.0144531181201896,0.0299639384094849,2.01010433944683e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,28740,-0.0846621430907712,0.00394710691208962,-0.0923984726384669,-0.0769258135430756,2.90000177388734e-101
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23475.Acetate,29192,0.0373881749929832,0.00390020094132576,0.0297437811479847,0.0450325688379817,9.83687584982109e-22
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23476.Acetoacetate,29216,-0.0156516500617663,0.00390697873852278,-0.023309328389271,-0.00799397173426166,6.18889159774929e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23477.Acetone,29216,0.00263925704644874,0.00390529133308234,-0.00501511396639266,0.0102936280592901,0.499163041441963
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23478.Creatinine,28483,0.0372471228420449,0.00462773930460645,0.0281767538050162,0.0463174918790735,8.69374525234333e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23479.Albumin,29215,-0.0478543591374887,0.00394798848764966,-0.0555924165732821,-0.0401163017016954,9.82958815725354e-34
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,29218,-0.0665979259435892,0.00414529079251449,-0.0747226958969176,-0.0584731559902608,7.83051380991429e-58
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,29218,-0.103344415756688,0.00413829906910656,-0.111455481932137,-0.0952333495812393,3.26183669037737e-136
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,29218,-0.0990302206753726,0.00413157790651177,-0.107128113372136,-0.0909323279786095,9.59491143535415e-126
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,29218,-0.104611382702048,0.00415402418749047,-0.112753270109529,-0.0964694952945666,1.84515587505977e-138
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,29218,-0.12815921728549,0.00409155947443197,-0.136178673855376,-0.120139760715603,7.34366155089105e-212
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,29218,-0.140255579592561,0.00406370693667454,-0.148220445188443,-0.132290713996679,6.86126978646045e-256
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,29218,-0.108329609316546,0.00411334503038287,-0.116391765576096,-0.100267453056995,4.3147013336163e-151
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,29218,-0.0810172432986409,0.00412368095602725,-0.0890996579724543,-0.0729348286248275,2.19339442352033e-85
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,29218,-0.159493919658827,0.00409900997944231,-0.167527979218534,-0.15145986009912,1.6688053938804e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,29218,-0.156068136671706,0.0040966983907586,-0.164097665517593,-0.148038607825819,1.68331456179075e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,29218,-0.156438622435471,0.00407107834097971,-0.164417935983791,-0.148459308887151,1.66880547791204e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,29218,-0.178198229176045,0.00395064145689603,-0.185941486431561,-0.170454971920529,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,29218,-0.189633626050854,0.00387477811641562,-0.197228191159028,-0.182039060942679,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,29218,-0.159113232679177,0.00403165873909711,-0.167015283807808,-0.151211181550547,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,29218,-0.141453362480701,0.00415370964518715,-0.149594633385268,-0.133312091576135,2.62341605273398e-249
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,29218,-0.167376555340846,0.00403665365384959,-0.175288396502391,-0.1594647141793,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,29218,-0.167035108756209,0.00402830547325296,-0.174930587483785,-0.159139630028634,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,29218,-0.16765219208931,0.00405005758452936,-0.175590304954987,-0.159714079223632,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,29218,-0.177282224816293,0.00393344614658647,-0.184991779263602,-0.169572670368983,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,29218,-0.173156875155901,0.00386406207890721,-0.180730436830559,-0.165583313481243,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,29218,-0.178646303435405,0.00401452253558498,-0.186514767605152,-0.170777839265659,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,29218,-0.154613949610529,0.00406281763769833,-0.162577072180418,-0.14665082704064,1.73131243356823e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,29218,-0.190272183357407,0.00374521345626063,-0.197612801731678,-0.182931564983136,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,29218,-0.186024136082468,0.00378735168136705,-0.193447345377948,-0.178600926786989,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,29218,-0.186161109906582,0.00374245030199215,-0.193496312498487,-0.178825907314677,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,29218,-0.17059934050653,0.00375514747942157,-0.177959429566196,-0.163239251446864,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,29218,-0.152821124250946,0.00382030319426848,-0.160308918511712,-0.14533332999018,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,29218,-0.183688550520606,0.00373055450913237,-0.191000437358505,-0.176376663682706,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,29218,-0.167056020307571,0.0039709071135206,-0.174838998250072,-0.159273042365071,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,29218,-0.172270569415476,0.00386373312232913,-0.179843486335241,-0.164697652495711,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,29218,-0.176977968507254,0.00384075676465937,-0.184505851765987,-0.169450085248522,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,29218,-0.188504176379218,0.00375027604928068,-0.195854717435808,-0.181153635322628,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,29218,-0.187670425005037,0.00373986115835351,-0.19500055287541,-0.180340297134664,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,29218,-0.18481769939441,0.00376244998035351,-0.192192101355902,-0.177443297432917,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,29218,-0.188980418480422,0.00371850791568263,-0.19626869399516,-0.181692142965684,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,29218,-0.125982767468765,0.00403313798363194,-0.133887717916684,-0.118077817020847,9.91768218148598e-211
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,29218,-0.138013389314698,0.00384872052229216,-0.14555688153839,-0.130469897091005,1.25299208104196e-275
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,29218,-0.129252256285322,0.0038716323966402,-0.136840655782737,-0.121663856787907,7.4974426469119e-240
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,29218,-0.123499208376424,0.00387190231516383,-0.131088136914145,-0.115910279838703,1.76502363777486e-219
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,29218,-0.123148226576461,0.00392832255809318,-0.130847738790324,-0.115448714362599,3.33831255996382e-212
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,29218,-0.115462004799646,0.00396711878015584,-0.123237557608752,-0.107686451990541,1.31334786181969e-183
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,29218,-0.136045456822398,0.00386380955473994,-0.143618523549688,-0.128472390095108,5.14679480396286e-266
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,29218,-0.105779013748776,0.0039854486973727,-0.113590493195627,-0.097967534301926,2.14251191705448e-153
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,29218,-0.151901951352625,0.00381696708638815,-0.159383206841945,-0.144420695863304,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,29218,-0.149717447323559,0.00391902607932308,-0.157398738439032,-0.142036156208085,1.66910567161189e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,29218,-0.144865431230877,0.00393039146490041,-0.152568998502082,-0.137161863959672,1.01661530159264e-290
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,29218,-0.143833403457108,0.00394276291012105,-0.151561218760945,-0.136105588153271,5.7158929463362e-285
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,29218,-0.142574874889839,0.00394270013380072,-0.150302567152088,-0.134847182627589,3.71089613791633e-280
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,29218,-0.143595851315871,0.00394151345186786,-0.151321217681532,-0.13587048495021,3.12753022798113e-284
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,29218,-0.111858402280751,0.0039415477693092,-0.119583835908597,-0.104132968652905,8.61402523866295e-175
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,29218,-0.176058363445975,0.00373711008959834,-0.183383099221588,-0.168733627670362,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,29218,-0.188011720129192,0.00374753622729229,-0.195356891134685,-0.1806665491237,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,29218,-0.189913041732228,0.00373931920849473,-0.197242107380877,-0.182583976083578,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,29218,-0.183642945976703,0.0037645654383631,-0.191021494235894,-0.176264397717511,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,29218,-0.187395954892047,0.00374474041244626,-0.194735646100441,-0.180056263683652,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,29218,-0.168975434540306,0.00383348352404934,-0.176489062247442,-0.161461806833169,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,29218,-0.141020535687493,0.00390823180785161,-0.148680670030882,-0.133360401344104,5.66841244952689e-279
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,29218,-0.203236855564564,0.00368786751302766,-0.210465075890098,-0.19600863523903,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,29218,-0.215940595891442,0.00365890646242896,-0.223112052557803,-0.208769139225081,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,29218,-0.211819762575987,0.00366290453944459,-0.218999055473298,-0.204640469678675,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,29218,-0.215121375999194,0.00365748234214495,-0.222290041389798,-0.20795271060859,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,29218,-0.219633557970197,0.0036602817896602,-0.226807710277931,-0.212459405662463,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,29218,-0.192066127807258,0.0037067839821804,-0.199331424412331,-0.184800831202184,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,29218,-0.152908282066527,0.00393317875352812,-0.160617312423442,-0.145199251709612,1.66880539388041e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,29218,-0.185159551226798,0.00371915625210808,-0.19244909748093,-0.177870004972666,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,29218,-0.199272195897818,0.00368811183176926,-0.206500895088086,-0.192043496707551,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,29218,-0.177845428554752,0.00372300957452003,-0.185142527320811,-0.170548329788692,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,29218,-0.203090775115249,0.0036778058685582,-0.210299274617623,-0.195882275612875,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,29218,-0.208012424102087,0.0036771221561197,-0.215219583528082,-0.200805264676093,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,29218,-0.172872823136009,0.00374130788120047,-0.180205786583162,-0.165539859688856,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,29218,-0.132023484232971,0.00400461386723677,-0.139872527412755,-0.124174441053187,4.61817168015557e-234
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,29218,0.100920334532344,0.00450472168740032,0.0920910800250397,0.109749589039649,3.11274769595793e-110
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,29218,0.140484779095619,0.0044885557506219,0.1316872098244,0.149282348366838,1.53868304377026e-211
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,29218,0.162694607498982,0.00445046520495338,0.153971695697273,0.171417519300691,3.95686272685936e-286
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,29218,0.118938213577914,0.00452109558078983,0.110076866239566,0.127799560916262,9.04521128851679e-151
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,29218,0.115821660045021,0.00457468473543476,0.106855277963569,0.124788042126473,6.56122705303318e-140
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,29218,0.122314949066746,0.00428480092426136,0.113916739255193,0.130713158878298,8.4135240507214e-177
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,29218,-0.0316589541535948,0.00393193320713994,-0.0393655432395891,-0.0239523650676005,8.46953686057511e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,29218,0.113876107715446,0.00465086556976493,0.104760411198706,0.122991804232185,4.49394062501357e-131
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,29218,0.126030437503093,0.00460557849467198,0.117003503653536,0.13505737135265,8.1906635571525e-163
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,29218,0.126338953676999,0.00455040123916588,0.117420167248234,0.135257740105765,1.75638612409243e-167
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,29218,0.125633912170926,0.00464186463799004,0.116535857480466,0.134731966861386,2.33578846978158e-159
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,29218,0.125764601091956,0.00464251269983407,0.116665276200281,0.134863925983631,1.22592143934387e-159
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,29218,0.123319503131675,0.00461477140132819,0.114274551185072,0.132364455078278,1.90064025732966e-155
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,29218,0.022390779113789,0.00402320353000481,0.0145053001949796,0.0302762580325984,2.63829254502554e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,29218,-0.0110676044486626,0.00425325961513294,-0.0194039932943232,-0.00273121560300209,0.00926890484896371
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,29218,-0.0122862763402783,0.00420051385815459,-0.0205192835022612,-0.00405326917829526,0.00344780891374487
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,29218,-0.0127366103987701,0.00415304796312761,-0.0208765844065002,-0.00459663639103997,0.002165538582383
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,29218,-0.000703845156376474,0.00428442225389561,-0.00910131277401187,0.00769362246125892,0.869511813048298
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,29218,0.0012221528916938,0.00427045228228877,-0.00714793358159218,0.00959223936497978,0.774736039690321
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,29218,-0.00857873711064007,0.00432028210418344,-0.0170464900348396,-0.000110984186440536,0.0470771908967694
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,29218,-0.0706829249688246,0.00396897062437843,-0.0784621073926063,-0.0629037425450429,1.42548274817301e-70
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,29218,-0.189658230510723,0.00371344050202796,-0.196936573894698,-0.182379887126748,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,29218,-0.166791787138911,0.00378012709575862,-0.174200836246598,-0.159382738031225,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,29218,-0.142841784855368,0.00383223890167609,-0.150352973102653,-0.135330596608083,4.0509287837411e-297
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,29218,-0.176902090028119,0.0037353539726245,-0.184223383814463,-0.169580796241775,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,29218,-0.173293405999469,0.00372923206910954,-0.180602700854924,-0.165984111144014,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,29218,-0.163272794784591,0.00382448837002481,-0.17076879198984,-0.155776797579343,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,29218,-0.138000978075242,0.00410355205183878,-0.146043940096846,-0.129958016053638,2.72734924011644e-243
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27965,-0.012807098355833,0.00397584192248634,-0.0205997485239062,-0.00501444818775979,0.00127788031944839
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27965,-0.0471513336539343,0.00401942137476973,-0.055029399548483,-0.0392732677593857,1.05077874098985e-31
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27965,-0.0747655246870394,0.00396727638466196,-0.0825413864009769,-0.066989662973102,9.84444089289329e-79
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27965,0.0119214028793456,0.00407354261564887,0.00393725935267386,0.0199055464060174,0.0034302663320726
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27965,0.0473812741878528,0.00395931483043374,0.0396210171202027,0.055141531255503,6.3652126531124e-33
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,28908,-0.0687511911941736,0.00385337031874333,-0.0763037970189105,-0.0611985853694367,8.03205389868463e-71
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,28908,0.00685813050563159,0.00422402989781053,-0.00142096809407704,0.0151372291053402,0.104472338291966
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,28908,0.00285408546244644,0.00421720943656186,-0.0054116450332148,0.0111198159581077,0.498556615929444
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,28908,0.0158621473751254,0.00409907892454523,0.00782795268301677,0.0238963420672341,0.000109214963064769
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,28908,0.0160999218544956,0.00411845099594203,0.00802775790244923,0.024172085806542,9.28067007621183e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,29213,-0.111586055545154,0.00406491638576651,-0.119553291661256,-0.103618819429051,8.15031036527207e-164
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,29213,-0.0302159035582302,0.00398537198759057,-0.0380272326539077,-0.0224045744625527,3.51166131144239e-14
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,29213,0.00254669804092176,0.00413728324641561,-0.00556237712205283,0.0106557732038964,0.53819742038042
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,29213,-0.0973998847368137,0.00386352035642421,-0.104972384635405,-0.0898273848382222,9.4776211205288e-139
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,29213,0.0702698409178391,0.00384744416764508,0.0627288503492548,0.0778108314864235,4.14274215035027e-74
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,29218,-0.0662924571750123,0.00406109317401206,-0.074252199796076,-0.0583327145539487,1.22865189120111e-59
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,29218,-0.007135816,0.004254415,-0.01547447,0.001202837,0.09349978
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,29218,0.00546605722464634,0.00428487161360252,-0.0029322911380146,0.0138644055873073,0.202084403196667
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,29218,-0.0415550530953485,0.00415112640896807,-0.0496912608569259,-0.0334188453337711,1.49513639644784e-23
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,29218,0.0210068973616622,0.00421903108395063,0.0127375964371189,0.0292761982862054,6.42505780271331e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,29218,-0.0619789504538376,0.00412453181524159,-0.0700630328117111,-0.0538948680959641,7.58351086113152e-51
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,29218,-0.0759417695234492,0.0039981768756825,-0.0837781961997869,-0.0681053428471116,5.79785859575523e-80
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,29218,-0.0797742346763833,0.0039029456530374,-0.0874240081563366,-0.07212446119643,3.29636329827161e-92
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,29218,-0.0606933230156554,0.00414921763830658,-0.0688257895867364,-0.0525608564445746,2.7739563049203e-48
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,29218,0.0730213903639956,0.00403811932993754,0.0651066764773181,0.0809361042506732,1.08182770057348e-72
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,29218,0.0282826874492858,0.00404104859024581,0.020362232212404,0.0362031426861675,2.63643025095069e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,29218,-0.0151249464722212,0.00422970834558119,-0.0234151748295603,-0.00683471811488204,0.000349609850574405
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,29218,-0.00209647704468498,0.00427185336155517,-0.0104693096333331,0.00627635554396315,0.6235962009332
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,29218,-0.0958940072290571,0.00388643282761247,-0.103511415571177,-0.0882765988869366,4.69392399556167e-133
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,29218,0.0105141392566121,0.00420351004801009,0.00227525956251228,0.0187530189507118,0.0123800959068848
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,29218,0.0723432399827035,0.00383535261531567,0.0648259488566847,0.0798605311087222,6.87473337093704e-79
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,29218,-0.0517499428770375,0.00404942134016977,-0.0596868087037703,-0.0438130770503048,2.683935483051e-37
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,29218,-0.0428693226599117,0.00402142035044212,-0.0507513065467782,-0.0349873387730451,1.74732001522142e-26
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,29218,-0.0323292176309292,0.00395346766469324,-0.0400780142537279,-0.0245804210081304,3.01593424245823e-16
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,29218,0.0368197240770904,0.00414250981568468,0.0287004048383485,0.0449390433158324,6.55587883934011e-19
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,29218,0.0217290302275323,0.00388775104352776,0.0141090381822179,0.0293490222728467,2.3028397452375e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,29218,-0.0715635444990053,0.00410738702184325,-0.079614023061818,-0.0635130659361925,1.2118998807302e-67
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,29218,-0.10336769808434,0.00382124346606584,-0.110857335277829,-0.0958780608908507,3.43549681253145e-159
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,29218,0.0276622867312615,0.00426215881773838,0.0193084554484942,0.0360161180140287,8.70921358907795e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,29218,0.0643072509182741,0.00406654777030526,0.0563368172884758,0.0722776845480724,4.27942067647044e-56
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,29218,0.0915106501851287,0.0038586608239149,0.0839476749702555,0.0990736254000019,3.63797507429478e-123
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,29218,-0.118163688822137,0.00387709779894986,-0.125762800508079,-0.110564577136195,7.31394887487081e-201
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,29218,-0.148797323709562,0.00387860756652459,-0.15639939453995,-0.141195252879174,1.66880624278946e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,29218,0.0681817620729644,0.00421278452231774,0.0599247044092216,0.0764388197367071,1.16858101776982e-58
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,29218,0.0868629152906687,0.00397064742574363,0.0790804463362112,0.0946453842451263,3.06593187881712e-105
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,29218,0.151188000946815,0.00381648230341868,0.143707695632114,0.158668306261515,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,29218,-0.153770615047945,0.00379285276503767,-0.161204606467419,-0.146336623628471,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,29218,-0.154692300276895,0.00380782159812354,-0.162155630609217,-0.147228969944573,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,29218,0.011331983927611,0.0040857589865915,0.00332389631389168,0.0193400715413304,0.00554865386162572
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,29218,0.0285769789636544,0.00409831150373656,0.0205442884163307,0.0366096695109781,3.17150070699807e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,29203,0.210719714540684,0.00420022232047414,0.202487278792555,0.218952150288814,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,29203,-0.147340670619099,0.00399097749951258,-0.155162986518144,-0.139518354720055,1.20498302307851e-291
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,29203,-0.115490691941417,0.00386581751752301,-0.123067694275762,-0.107913689607072,3.39892244822928e-193
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,29203,-0.117995922235177,0.00455316116231894,-0.126920118113322,-0.109071726357031,2.04143915240123e-146
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,29203,-0.136867532661532,0.00424562799838128,-0.145188963538359,-0.128546101784705,4.53449912684028e-224
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,29218,-0.029369334329397,0.00429168138279915,-0.0377810298396833,-0.0209576388191107,7.89079105200311e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,29218,0.0754690213246334,0.00438506296468789,0.0668742979138452,0.0840637447354217,4.69624245053392e-66
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,29218,0.060217077451149,0.00432447561732139,0.051741105241199,0.0686930496610989,6.1973272780425e-44
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,29218,0.0653671090018823,0.00423596471170313,0.0570646181669442,0.0736695998368205,1.63652261937146e-53
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,29218,-0.0812102860711252,0.00421888040288005,-0.0894792916607701,-0.0729412804814803,4.62265194293993e-82
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,29218,-0.00487601919969467,0.00434331780745513,-0.0133889221023067,0.00363688370291739,0.261596039920486
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,29218,0.0462279380661084,0.00426605997761706,0.0378664605099789,0.0545894156222378,2.61358451192212e-27
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,29218,0.0458195661580195,0.00415007308591943,0.0376854229096174,0.0539537094064216,2.7669424538517e-28
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,29218,0.00943830031246071,0.00453038627762861,0.000558743208308628,0.0183178574166128,0.0372296149442191
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,29218,-0.0683981133306178,0.00415994771895821,-0.0765516108597758,-0.0602446158014597,1.78876633407264e-60
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,29218,0.14230475375227,0.00390151871452225,0.134657777071806,0.149951730432733,7.08825614177097e-285
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,29218,-0.0525965899477554,0.00397685515202256,-0.0603912260457196,-0.0448019538497912,8.1209300411443e-40
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,29218,-0.0549073227948116,0.00394980014068842,-0.0626489310705609,-0.0471657145190623,8.58038009337297e-44
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,29218,-0.0143870227317297,0.00415575309106282,-0.0225322987902129,-0.0062417466732466,0.00053703751079464
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,29218,-0.0713620502347116,0.00422900199630102,-0.0796508941474616,-0.0630732063219616,1.38935499326358e-63
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,50365,0.00200927361512471,0.00335940521820949,-0.00457516061256589,0.00859370784281532,0.549773248197056
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,50365,0.0055319174298658,0.00327833603630358,-0.000893621201289213,0.0119574560610208,0.0915295393320123
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46971,0.00532488891908934,0.00313591714802699,-0.000821508691043566,0.0114712865292223,0.089508272581203
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46971,0.00577018476978489,0.00341089516598683,-0.000915169755549294,0.0124555392951191,0.0907113103904371
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46971,0.00136415602339901,0.00336375944028482,-0.00522881247955924,0.00795712452635727,0.685078751499124
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46971,0.00302237092721792,0.0030879442359398,-0.0030299997752241,0.00907474162965993,0.327701279546338
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,50365,0.00756187719110489,0.0277652003007578,-0.0468579153983803,0.0619816697805901,0.785353341804468
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,50365,0.000815838222599727,0.00293801318395841,-0.00494266761795876,0.00657434406315821,0.781256353221675
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,50365,0.00127937660048442,0.00293772209970176,-0.00447855871493102,0.00703731191589986,0.663201745195972
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,50365,0.00176768251566794,0.00298417718273342,-0.00408130476248957,0.00761666979382545,0.553617742616959
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,50365,-0.00350995691070087,0.0193725206954618,-0.041480097473806,0.0344601836524042,0.856225254823395
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,50365,-0.00302923399398829,0.0188229935790431,-0.0399223014089127,0.0338638334209361,0.872147102336887
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,50365,0.000125675547284854,0.00335745416473145,-0.0064549346155888,0.0067062857101585,0.970140867401331
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,50365,0.000777323280228644,0.00335317618190317,-0.00579490203630157,0.00734954859675886,0.816681086028917
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,50365,0.000625685737170525,0.00331844102479952,-0.00587845867143654,0.00712983014577759,0.85044777620531
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,50264,0.000427829854665375,0.00325893352120548,-0.00595967984689736,0.00681533955622811,0.895555051233849
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,50365,0.000981959603290092,0.002948123199848,-0.00479636186841199,0.00676028107499217,0.739075608464069
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,50365,0.000967034373438636,0.00294803854496277,-0.0048111211746884,0.00674518992156567,0.742893090664714
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,50365,0.000990230294122267,0.00294814646771488,-0.00478813678259891,0.00676859737084344,0.736961004625308
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,50365,0.000997519258451301,0.00294797458720805,-0.00478051093247647,0.00677554944937907,0.735082441963994
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,50365,0.000991576676892353,0.00294798851724156,-0.00478648081690111,0.00676963417068582,0.736603046659106
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2405.Number of children fathered,23164,-0.0694898539481586,0.0215874525341601,-0.111801260915112,-0.0271784469812049,0.00128818983285498
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44931,-0.00241273004010329,0.00346002273308252,-0.00919437459694503,0.00436891451673845,0.485608516532981
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44931,2.14759262334518e-05,0.00313483964048893,-0.00612280976912486,0.00616576162159176,0.994533984978836
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",44931,-0.00229153260171555,0.00312031076279023,-0.00840734169678439,0.0038242764933533,0.462713433125244
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44931,-0.00440325041786743,0.00325599167910224,-0.0107849941089078,0.00197849327317297,0.176269195680839
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44931,0.00283567155948298,0.00316243827996828,-0.00336270746925485,0.00903405058822081,0.369898484193618
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",44931,-0.000688342568121242,0.0031380985667188,-0.00683901575889008,0.0054623306226476,0.826378251735721
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",50599,-0.00414953595314552,0.0033062812439856,-0.0106298471913573,0.00233077528506625,0.209467760509157
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",50599,-0.00732651248865686,0.00310932843745367,-0.013420796226066,-0.00123222875124768,0.0184617657893337
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,50599,-0.00438130816520816,0.00295840029834911,-0.0101797727499724,0.00141715641955609,0.138620249074688
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,11137,-0.0114767925496909,0.02809837530142,-0.0665496081404741,0.0435960230410922,0.682950902850677
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,20936,-0.0638958385865385,0.0203984388567488,-0.103876778745766,-0.0239148984273109,0.00173629290058043
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),26697,-0.0138025178032822,0.0171685379030416,-0.0474528520932438,0.0198478164866793,0.421437328113535
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2734.Number of live births,27519,-0.0495752202575584,0.0165346719379186,-0.0819831772558789,-0.0171672632592379,0.00271769964185667
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2744.Birth weight of first child,21843,-0.0325750658878254,0.01845927482654,-0.0687552445478439,0.00360511277219308,0.0776283350393121
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2754.Age at first live birth,18593,0.00585786288228826,0.00516377471055736,-0.00426313555040416,0.0159788613149807,0.256635194442132
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2764.Age at last live birth,18547,0.00410407341835081,0.00499007147322233,-0.00567646666916495,0.0138846135058666,0.410832651849146
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,21109,0.017107997986107,0.00558009518656391,0.00617101142044179,0.0280449845517723,0.00217292281581813
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,19153,-0.00148780366340768,0.00483327394519452,-0.0109610205959889,0.00798541326917358,0.758218671970026
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,12451,0.00323063726887427,0.00593620044033391,-0.00840431559418019,0.0148655901319287,0.586295411670455
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19438,0.0507654930814849,0.024966489293275,0.00183117406666596,0.0996998120963039,0.0420312197942417
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19429,0.0166992679800195,0.0275786485133701,-0.0373548831061858,0.0707534190662248,0.544844358155702
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19466,0.0141267921493808,0.0284046338165088,-0.0415462901309764,0.069799874429738,0.618954147269168
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19413,0.0151092471639604,0.0277691964293653,-0.0393183778375957,0.0695368721655165,0.586378235818892
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,19486,0.105514909455284,0.0242233972406387,0.058037050863632,0.152992768046936,1.33193225516497e-05
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,19531,0.0852718616032101,0.0269345897334003,0.0324800657257455,0.138063657480675,0.00154848687678945
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28741.Difficulty learning a new task,19376,0.0739823344082302,0.0306560655101975,0.0138964460082432,0.134068222808217,0.0158179547248084
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,18671,0.0490947418159869,0.0307044525705199,-0.011085985222232,0.109275468854206,0.109849681134221
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,19401,0.0249959679942285,0.0261530429683038,-0.0262639962236469,0.076255932212104,0.339206663978477
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19532,0.0658618222229489,0.0371194827517652,-0.00689236397051093,0.138616008416409,0.0760259038422083
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11825,-0.0319739025614043,0.0280750367773542,-0.0870009746450185,0.0230531695222099,0.254779210881049
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,12456,0.0106243525677999,0.0062041114704604,-0.00153570591430246,0.0227844110499023,0.0868350706912644
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17422,-0.0269566288490595,0.0104183966664143,-0.0473766863152316,-0.00653657138288738,0.00967816588392433
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17422,0.0198815055452734,0.0113527513754722,-0.00236988715065202,0.0421328982411989,0.079920471516326
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17422,-0.0393459358384338,0.0377206948253809,-0.11327849769618,0.0345866260193127,0.296922861270362
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17422,-0.0274021938930994,0.0388272952767876,-0.103503692635603,0.0486993048494043,0.480355784178933
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17422,0.0122874384248357,0.0430169860048936,-0.0720258541447557,0.0966007309944271,0.775156077351812
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17422,-0.0197876806059158,0.0366749670032823,-0.0916706159323492,0.0520952547205175,0.589519909129704
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17422,0.00939646326467618,0.0163616863441704,-0.0226724419698978,0.0414653684992502,0.565774429762577
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17422,0.0343163770649031,0.0294454138433604,-0.0233966340680832,0.0920293881978895,0.243863580473131
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,17304,0.0290551780007497,0.02888858608827,-0.0275664507322596,0.0856768067337589,0.314541884372488
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29003.Recent feelings of depression,17291,0.0226934579844724,0.0279749214082526,-0.0321373879757027,0.0775243039446475,0.41725786117858
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17314,0.0191666684159128,0.0226260998651857,-0.0251804873198512,0.0635138241516768,0.396948660670315
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,17324,0.0433229743482184,0.0228540088131368,-0.00147088292552982,0.0881168316219666,0.0580243007390869
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,17336,0.0140260854216975,0.0314754841514441,-0.0476658635151329,0.0757180343585279,0.655877785972444
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,17266,0.0525237223166217,0.0304862670969568,-0.0072293611934137,0.112276805826657,0.0849308646446592
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,17332,0.0284428585472641,0.0301013442532374,-0.0305557761890812,0.0874414932836093,0.344721447205814
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17317,0.0670403575361313,0.0528001388652028,-0.0364479146396662,0.170528629711929,0.204208447259258
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,17232,0.0265196963686184,0.058617348304083,-0.0883703063073843,0.141409699044621,0.650971704022375
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,15918,0.00131218466719403,0.0202380831177291,-0.0383544582435551,0.0409788275779431,0.948304279002934
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),15918,-0.025370748848439,0.0395439400470151,-0.102876871340589,0.0521353736437105,0.52115274099752
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),15918,0.0368464989341997,0.0201747818812907,-0.00269607355313002,0.0763890714215294,0.0678141607856369
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),15918,0.0435349091108728,0.0585260491125912,-0.0711761471498059,0.158245965371552,0.45697503767343
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),15918,0.0364383555005534,0.037813106925569,-0.0376753340735618,0.110552045074669,0.335239330861372
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),15918,0.0216479036211851,0.0403431491000246,-0.0574246686148631,0.100720475857233,0.591555391787534
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),15918,0.0459184771458045,0.0447532384434364,-0.0417978702033309,0.13363482449494,0.30488976341813
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),15918,0.00568363272500568,0.0528003544179714,-0.0978050619342182,0.10917232738423,0.914279580227444
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),15918,0.0138472299414383,0.0394676744206521,-0.0635094119230397,0.0912038718059163,0.72570560006018
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,15918,0.00777754495879132,0.0199062605878993,-0.0312387257934914,0.046793815711074,0.696017957998976
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,15918,-0.0184433652320586,0.0308727912862754,-0.0789540361531584,0.0420673056890412,0.550249729778088
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,15918,0.0304921606552017,0.0486607199796612,-0.0648828505049343,0.125867171815338,0.530912225043757
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,15918,0.0685756389609947,0.0631761146500351,-0.0552495457530742,0.192400823675064,0.277730964948658
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,15918,0.0604870890395188,0.0390322921987707,-0.0160162036700718,0.136990381749109,0.121241151802563
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,15918,0.156167053940868,0.0640344778117018,0.030659477429932,0.281674630451803,0.0147471304311825
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,15918,0.0062253862981831,0.0623272877597958,-0.115936097711017,0.128386870307383,0.92043911106966
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,15918,0.035756509917389,0.0334798472701556,-0.029863990732116,0.101377010566894,0.285536277192372
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,15918,0.0713219889558433,0.0323888722220171,0.00783979940068986,0.134804178510997,0.0276759186588421
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,15918,0.0821043683100039,0.0464607836439708,-0.00895876763217895,0.173167504252187,0.0772179809569788
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,17058,-0.00369213563426472,0.0263936757011138,-0.0554237400084478,0.0480394687399184,0.88875082047769
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,17077,0.0112900367134105,0.0274293958446329,-0.04247157914207,0.065051652568891,0.680635199421637
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29060.Recent worrying too much about different things,17065,-0.00397517698962751,0.025271740574884,-0.0535077885164002,0.0455574345371452,0.875012397315227
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29061.Recent trouble relaxing,17070,0.0171702460202203,0.0267753013301883,-0.0353093445869487,0.0696498366273894,0.521354717083675
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29062.Recent restlessness,17088,0.0567589058701698,0.0381840267462011,-0.0180817865523844,0.131599598292724,0.137176804443289
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,17041,0.0716074556565854,0.0272361634766961,0.0182245752422611,0.12499033607091,0.00856801617524896
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29064.Recent feelings of foreboding,17036,0.00676591446556088,0.0310119020183778,-0.0540174134904596,0.0675492424215814,0.827298073271485
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,15918,-0.00155967523705035,0.0212925286618731,-0.0432930314143217,0.040173680940221,0.941608193095548
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,15918,0.0465349735481925,0.0358017278176731,-0.0236364129744468,0.116706360070832,0.193689439013916
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',15918,0.0282837683130252,0.0461588861233701,-0.0621876484887802,0.118755185114831,0.540051694883466
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,15918,0.053005239444386,0.0487734666526387,-0.0425907551947857,0.148601234083558,0.277157666860696
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,15918,0.00905514279385044,0.03213742843987,-0.0539342169482947,0.0720445025359956,0.778128801170625
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,15918,0.0160148393981623,0.0345414349640937,-0.0516863731314613,0.083716051927786,0.642911030190477
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,15918,0.0305734645758428,0.0345310951457954,-0.0371074819099161,0.0982544110616018,0.375960049640068
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,15918,0.03138129737248,0.0319581007577958,-0.0312565801127998,0.0940191748577598,0.326138796803192
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,15918,-0.033943640231095,0.0423887353964963,-0.117025561608228,0.0491382811460379,0.423276599662308
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29076.Felt loved as a child,17004,-0.0229499761529354,0.0236575924741593,-0.0693188574022876,0.0234189050964168,0.332015818731808
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29077.Physically abused by family as a child,17028,0.0639827009167202,0.031746933370521,0.00175871151049903,0.126206690322941,0.0438786776665316
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29078.Felt hated by family member as a child,16998,0.109070251049418,0.0321796771981837,0.0459980837409778,0.172142418357858,0.000702014587323827
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29079.Sexually molested as a child,16874,0.0624463596016859,0.0429596065111136,-0.0217544691600969,0.146647188363469,0.146074073583569
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,16969,-0.0446536217096232,0.0343616051700686,-0.112002367842958,0.0226951244237113,0.193782921018401
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,17007,-0.0328968218808763,0.044179934377093,-0.119489493259979,0.053695849498226,0.456517805595434
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,16901,0.02093922780629,0.0345348922040329,-0.0467491609136144,0.0886276165261944,0.544309816359788
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,17019,-0.00728173674989339,0.0387152853805496,-0.0831636960957707,0.0686002225959839,0.850812824765202
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,16969,-0.0121801490575854,0.0540529133683379,-0.118123859259528,0.0937635611443569,0.821719434958321
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,16967,-0.00869003013161729,0.051823971794514,-0.110265014848865,0.0928849545856302,0.866834199430491
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,17020,-0.0268789371094344,0.0438670061331265,-0.112858269130362,0.0591003949114936,0.540058456690393
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,17021,0.0853278769002389,0.0279585174830171,0.0305291826335254,0.140126571166952,0.0022771389764057
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,17028,-0.0704494862588569,0.0258103177983143,-0.121037709143553,-0.0198612633741608,0.00634939976084346
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,17048,-0.00645531991197651,0.0347913767484776,-0.0746464183389926,0.0617357785150396,0.852804836266064
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,17023,0.00811775512477762,0.0323420256533653,-0.0552726151558183,0.0715081254053735,0.801819371995153
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,17031,-0.279492992529886,0.0214892553756036,-0.321611933066069,-0.237374051993703,1.72210043776436e-38
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15181,-0.273953179062432,0.0247736886192062,-0.322509608756077,-0.225396749368788,2.56606105654487e-28
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15219,-0.312440637031299,0.0252100006394154,-0.361852238284553,-0.263029035778044,4.1864211283036e-35
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29104.Ever used cannabis,17018,-0.0283804682928559,0.0310002633136159,-0.0891409843875431,0.0323800478018314,0.359946804332275
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29108.Ever thought that life not worth living,16939,0.0856285830872641,0.0269643453665529,0.0327784661688205,0.138478700005708,0.00149783463172575
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29109.Ever contemplated self-harm,16981,0.0661001799947306,0.0362986746995082,-0.00504522241630548,0.137245582405767,0.0686232330299228
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29111.Ever self-harmed,17006,0.00253836909319385,0.0582158114813198,-0.111564621410193,0.116641359596581,0.965221577186553
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,17002,0.0766767836141681,0.0384821361261396,0.0012517968069346,0.152101770421402,0.0463289890286793
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17264,0.070803060652531,0.0448584078816464,-0.0171194187954959,0.158725540100558,0.114499504583317
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17264,-0.0122621054270216,0.0347611186801051,-0.0803938980400276,0.0558696871859843,0.724277575405471
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17264,0.0476010234889426,0.037183960432945,-0.0252795389596295,0.120481585937515,0.200509822967528
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17264,0.017126533967733,0.0500313647149597,-0.080934940873588,0.115188008809054,0.732117306657566
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,16985,0.0120707989358483,0.0241142770864638,-0.0351931841536209,0.0593347820253174,0.616682745646203
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X29153.Pain or discomfort today,17012,0.00286208748893162,0.0227257425760615,-0.0416803679601489,0.0474045429380122,0.899780648900427
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29154.Anxiety or depression today,17012,0.0292686041453341,0.0283538672759819,-0.0263049757155904,0.0848421840062586,0.30196434418913
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,16595,-0.0426393575583649,0.0222461001281008,-0.0862417138094425,0.000962998692712651,0.0552917576089275
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,16960,0.0062965674551793,0.0106037584540291,-0.0144867991147177,0.0270799340250763,0.552650302302321
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,16960,-0.00579540019153409,0.010637125682257,-0.0266441665287577,0.0150533661456896,0.585879229378389
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,16960,-0.0906390542492208,0.0132650126308997,-0.116638479005784,-0.0646396294926574,8.6021873493056e-12
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,16960,0.0635599043654116,0.0143349750833018,0.0354633532021401,0.0916564555286831,9.31235771769882e-06
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,16960,0.0379152424272006,0.0231643640107114,-0.00748691103379371,0.083317395888195,0.10169253635259
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,16960,0.0159413270323108,0.010949376342384,-0.00551945059876181,0.0374021046633834,0.145435508204035
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,16956,-0.0159525759850663,0.0119082740884499,-0.039292793198428,0.00738764122829552,0.180386508690126
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,16956,0.0128570852756682,0.0173589655217468,-0.0211664871469555,0.046880657698292,0.458910096917998
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,16956,-0.106135058055878,0.0269744765786334,-0.159005032149999,-0.0532650839617564,8.36512792253953e-05
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,16956,0.0711210854610704,0.024088371124286,0.0239078780574698,0.118334292864671,0.00315637260791024
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,16956,0.0259984448663596,0.0357854045902328,-0.0441409481304967,0.0961378378632158,0.467536377848584
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,16956,0.000452357742175873,0.0171375694323669,-0.0331372783452633,0.034041993829615,0.978942053325333
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,16670,-0.0641830371214575,0.0277248356776421,-0.118523715049636,-0.00984235919327905,0.0206249426358746
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,16891,0.0693775346102966,0.0252286368060272,0.0199294064704833,0.11882566275011,0.00596674973800991
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29173.Frequency of feeling left out,16806,0.0676912827251746,0.02619153786675,0.0163558685063446,0.119026696944005,0.00976119585308679
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,16870,0.105220257959252,0.0271242107386495,0.0520568049114987,0.158383711007005,0.000105198557729263
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,16991,-0.068817757083186,0.0225053340521815,-0.112928211825462,-0.0247073023409102,0.00223283969060709
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29176.Ability to make it through stressful events,16991,0.0535341754249013,0.0217801636831834,0.0108450546058619,0.0962232962439407,0.0139838575964189
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29177.Quick recovery from stressful events,16991,-0.0342099946668809,0.0221680317254083,-0.0776593368486812,0.00923934751491932,0.122797746854069
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,16991,0.0490060936453094,0.0218413663292309,0.00619701564001671,0.091815171650602,0.0248627216846539
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,16991,-0.0694839440022819,0.0221426125716333,-0.112883464642683,-0.0260844233618805,0.00170384785524955
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,16991,0.0739915726238508,0.0220210908351336,0.0308302345869889,0.117152910660713,0.000781050917756359
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29181.General happiness,16897,0.0574557804602361,0.0228495792185317,0.012670605191914,0.102240955728558,0.0119285909348367
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29182.Belief that own life is meaningful,16704,-0.0635871283137463,0.0228478307501145,-0.108368876583971,-0.0188053800435218,0.00539076071500476
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11336,-0.024237375458696,0.0267937881954301,-0.0767532003217389,0.0282784494043469,0.365702228436923
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2946.Father's age,11150,0.0066055816423342,0.00956826053854908,-0.012148209013222,0.0253593722978904,0.489979761717727
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,12731,-0.0154560023825319,0.00734601861199727,-0.0298541988620465,-0.00105780590301723,0.0353982750541547
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,49433,0.0215365551414285,0.00312424210618788,0.0154130406133003,0.0276600696695568,5.51379163584971e-12
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,49434,-0.0585134868840841,0.00348209589980181,-0.0653383948476957,-0.0516885789204726,3.41347430372843e-63
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,49434,-0.0779749398320223,0.00371828725379554,-0.0852627828494615,-0.070687096814583,3.2292994631343e-97
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,49434,-0.0673669662071171,0.00363717794290246,-0.0744958349752059,-0.0602380974390283,2.50163602335387e-76
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,49434,0.00267625503592961,0.00308487963255964,-0.00337010904388729,0.00872261911574651,0.385650673148117
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,49433,-0.00645627625948084,0.00309409889692244,-0.0125207100974488,-0.000391842421512864,0.0369256336142918
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,49433,-0.019544196797185,0.0030177791967792,-0.0254590440228723,-0.0136293495714978,9.48467684022033e-11
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,49434,0.0504160468989041,0.003006933681258,0.0445224568836384,0.0563096369141698,6.3971710085664e-63
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30080.Platelet count,49434,-0.0231174679382371,0.00308570260926223,-0.0291654450523911,-0.0170694908240831,6.90645436700186e-14
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30090.Platelet crit,49434,-0.00660102092485347,0.0031536848429687,-0.0127822432170721,-0.000419798632634819,0.0363440918588987
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,49434,0.0341723083320128,0.00295433341992744,0.028381814828955,0.0399628018350706,6.65042890208559e-31
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,49434,-0.00331896664113271,0.00299357455814673,-0.00918637277510029,0.00254843949283488,0.267566382628745
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,49363,0.00066334515487007,0.00307517369194011,-0.00536399528133255,0.00669068559107269,0.829214839865254
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30130.Monocyte count,49363,0.0512614510872544,0.0030976534050296,0.0451900504133964,0.0573328517611124,2.40415429363661e-61
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30140.Neutrophill count,49363,0.0149336437411336,0.00309015761931958,0.00887693480726726,0.020990352675,1.35133076569816e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30150.Eosinophill count,49363,0.0306089244748881,0.00300790993251905,0.0247134210071507,0.0365044279426254,2.67810551181815e-24
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30160.Basophill count,49363,0.0551295756207807,0.0139921382270377,0.0277049846957868,0.0825541665457746,8.15802970671627e-05
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,49363,0.21801012018992,0.0644085451995137,0.0917693715988734,0.344250868780967,0.000712852666617076
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,49364,-0.0173698528052988,0.00302630487006502,-0.0233014103506262,-0.0114382952599713,9.54411689640506e-09
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,49364,0.0401152219419134,0.00306177449069431,0.0341141439401526,0.0461162999436743,3.73077684976665e-39
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,49364,-0.0021038538723107,0.00299732508567191,-0.00797861104022764,0.00377090329560625,0.482738306627566
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,49364,0.0242951482023853,0.00297582366888193,0.0184625338113767,0.0301277625933938,3.31218399799501e-16
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30220.Basophill percentage,49364,0.0062374853626147,0.00296189711579478,0.000432167015656922,0.0120428037095725,0.0352173078319997
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,49362,0.218169869778856,0.0644900282464434,0.0917694144158266,0.344570325141885,0.000717539064645605
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,48573,-0.0783786667502737,0.00317192015900605,-0.0845956302619256,-0.0721617032386219,5.61477976407442e-134
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,48573,-0.0901764284290071,0.00323562951178241,-0.0965182622721006,-0.0838345945859136,1.34976230973501e-169
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,48573,0.0151702138276201,0.00304289322096283,0.00920614311453292,0.0211342845407072,6.20279472821768e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,48573,0.0196902511196509,0.00306851765241303,0.0136759565209214,0.0257045457183805,1.40390678628329e-10
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,48573,-0.0294999709099226,0.00318561747305226,-0.0357437811571051,-0.0232561606627402,2.1177817699645e-20
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,48573,-0.0751546604626151,0.00324252939539299,-0.0815100180775853,-0.0687993028476448,3.35242407432556e-118
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,48573,-0.0848288961641068,0.00328832780384877,-0.0912740186596504,-0.0783837736685632,9.24666637274018e-146
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,16073,0.00912246510795212,0.00541839935937408,-0.00149759763642106,0.0197425278523253,0.0922767232612998
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,49532,0.00997953691708036,0.00322554679871161,0.0036574651916056,0.0163016086425551,0.00197650378842344
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30520.Potassium in urine,49432,-0.0265133547580711,0.00300143036272972,-0.0323961582690213,-0.0206305512471208,1.04634181011198e-18
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30530.Sodium in urine,49416,0.0100712378430773,0.00314089012989155,0.00391509318848986,0.0162273824976647,0.00134449730180355
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30600.Albumin,44532,-0.0652022808180641,0.0032219104758375,-0.0715172253507056,-0.0588873362854227,1.18123350311658e-90
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,48620,0.0538915514593021,0.00309769861627145,0.0478200621714101,0.0599630407471942,1.38727821135757e-67
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,48616,-0.0231631620045699,0.00328250290365935,-0.0295968676957422,-0.0167294563133975,1.72958330398629e-12
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,44254,-0.0405491688346107,0.00353717771329693,-0.0474820371526727,-0.0336163005165487,2.21598287794184e-30
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,48363,-0.205023911495807,0.00285735025473371,-0.210624317995085,-0.199423504996529,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,48481,0.021813049047709,0.00311582607558039,0.0157060299395715,0.0279200681558466,2.57938492488603e-12
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,41281,-0.0394574019180454,0.00335920775199816,-0.0460414491119618,-0.032873354724129,8.31653891286288e-32
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30670.Urea,48599,0.0872800395744399,0.00314872905615949,0.0811085306243673,0.0934515485245125,8.36356342930841e-168
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30680.Calcium,44528,-0.0454239412359133,0.00312975106389178,-0.0515582533211412,-0.0392896291506854,1.27694500009499e-47
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30690.Cholesterol,48631,-0.174791718891201,0.00294726617700782,-0.180568360598137,-0.169015077184266,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30700.Creatinine,48611,0.0782514715627132,0.00366867035306,0.0710608776707156,0.0854420654547108,1.74403208798685e-100
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30710.C-reactive protein,48488,-0.0206990211734176,0.00336472792262596,-0.0272938879017645,-0.0141041544450707,7.72221145671819e-10
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30720.Cystatin C,48631,0.0481055642499414,0.00351402150087235,0.0412180821082316,0.0549930463916512,1.40536864778243e-42
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,48612,-0.0769945371952022,0.00332939333721979,-0.0835201481361529,-0.0704689262542514,1.10629678450491e-117
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30740.Glucose,44479,-0.0168964933077387,0.00322338832571845,-0.0232143344261469,-0.0105786521893305,1.59705838805872e-07
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),48351,0.0365073650213323,0.00325678187002987,0.0301240725560737,0.0428906574865908,3.97233201533098e-29
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,44503,0.00168547030724424,0.00369545541187117,-0.00555762230002324,0.00892856291451173,0.648325531888116
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30770.IGF-1,48377,0.0128052788168966,0.00314375531431901,0.00664351840083134,0.0189670392329619,4.64368459470749e-05
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30780.LDL direct,48524,-0.184954759267995,0.00289362768257078,-0.190626269525834,-0.179283249010156,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,38867,0.0182479159514336,0.00335852574064089,0.0116652054997775,0.0248306264030898,5.56495290384448e-08
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30810.Phosphate,44427,0.0469306829202001,0.00323668986424243,0.0405867707862849,0.0532745950541153,1.56545280045678e-47
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30830.SHBG,44116,0.0827535773695897,0.00370878040796076,0.0754843677699866,0.0900227869691928,1.12377656633418e-109
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30840.Total bilirubin,48446,-0.130207625065832,0.0031440405597973,-0.136369944563035,-0.124045305568629,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30850.Testosterone,43931,-0.0378159380666792,0.00522222020482583,-0.0480514896681379,-0.0275803864652206,4.51501206509283e-13
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30860.Total protein,44494,-0.0642812343666989,0.00317508037473031,-0.0705043919011703,-0.0580580768322275,9.98534054972526e-91
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30870.Triglycerides,48594,-0.0971148750352227,0.00324605127399237,-0.103477135532248,-0.0907526145381977,6.83420946141414e-195
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30880.Urate,48566,-0.0783182461748952,0.00375134477573253,-0.085670881935331,-0.0709656104144595,2.28376282701319e-96
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30890.Vitamin D,46423,0.0254461995266974,0.00337193022249881,0.0188372162905997,0.0320551827627951,4.55336081716189e-14
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3137.Number of measurements made,46213,0.0166138474610678,0.0161409356506226,-0.0150223864141524,0.0482500813362881,0.303344624440169
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3143.Ankle spacing width,28912,-0.00721694768819316,0.00531561469424173,-0.017635552488907,0.00320165711252063,0.174573223587255
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",28910,-0.0147522538016472,0.00408765171096114,-0.0227640511551311,-0.00674045644816339,0.000307922281253616
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3146.Speed of sound through heel,28912,-0.0194932457608238,0.00395275018652368,-0.0272406361264102,-0.0117458553952374,8.20254820735767e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",28912,-0.0182753211176532,0.00399231575660735,-0.0261002600006036,-0.0104503822347028,4.7224381861416e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),28890,-0.0186226880850445,0.00399775456243739,-0.0264582870274218,-0.0107870891426672,3.20271607885569e-06
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3526.Mother's age at death,30390,0.001147111,0.003933488,-0.006562526,0.008856748,0.7705739
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),15750,-0.00464753044238581,0.00538821176106886,-0.0152084254940808,0.00591336460930915,0.38840538502027
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",10046,-0.000525737624718887,0.00688101938282173,-0.0140125356150495,0.0129610603656117,0.939099185532926
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4100.Ankle spacing width (left),16386,-0.0147153980885094,0.00722666796210087,-0.0288796672942271,-0.000551128882791725,0.0417399925699906
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16382,-0.00441756319197881,0.00556480776751798,-0.0153245864163141,0.00648946003235644,0.427300489298367
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),16386,-0.018261121614991,0.0053869470347403,-0.028819537803082,-0.00770270542690005,0.000700874277972836
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16386,-0.0141762108845012,0.00544089375231862,-0.0248403626390457,-0.00351205912995669,0.00918251347801536
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),16373,-0.0145957534795677,0.00544956642763052,-0.0252769036777235,-0.00391460328141185,0.00740635479328959
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16386,-0.0141738694059382,0.00544090521439258,-0.0248380436261477,-0.00350969518572878,0.0091941975489271
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4119.Ankle spacing width (right),16383,-0.0200327011899064,0.0071049506788569,-0.033958404520466,-0.00610699785934693,0.00481501254310822
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16382,-0.00679627708930421,0.00558019544998134,-0.0177334601712676,0.00414090599265921,0.22326883618201
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),16383,-0.0197132672060097,0.00538720866049439,-0.0302721961805787,-0.00915433823144065,0.000253726308947728
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16383,-0.015948140526284,0.00544559753974967,-0.0266215117041933,-0.00527476934837463,0.00340928693220501
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),16369,-0.0159458415661272,0.00545399486650176,-0.0266356715044706,-0.00525601162778374,0.0034637288943094
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16383,-0.0159478325013711,0.00544561117270922,-0.0266212303998811,-0.00527443460286098,0.00340998737839261
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4194.Pulse rate,17033,0.0349300361314274,0.00518785558484262,0.0247618391851359,0.0450982330777189,1.71464199901692e-11
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4195.Pulse wave reflection index,17033,-0.0277617045405305,0.00532667407304815,-0.0382019857237049,-0.0173214233573561,1.89173903153664e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,17022,0.0141425451288196,0.00529414930492346,0.0037660124911696,0.0245190777664696,0.00756179292566417
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,17033,-0.0219773575955988,0.00535285824374417,-0.0324689597533374,-0.0114857554378602,4.0493199198431e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4199.Position of pulse wave notch,17033,0.0317274179841392,0.00517879107361503,0.0215769874798538,0.0418778484884247,9.18583299695339e-10
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,17033,-0.00426210410782598,0.0053833276939766,-0.0148134263880201,0.00628921817236816,0.428533268978541
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),16705,0.0316634998773441,0.0689726143112892,-0.103522824172783,0.166849823927471,0.646187364626648
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4270.Volume level set by participant (left),16533,-0.00183291135460335,0.021443424455171,-0.0438620232867385,0.0401962005775318,0.931883521355669
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),16713,0.0105667016533028,0.0670724015691428,-0.120895205422217,0.142028608728823,0.8748198351116
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4277.Volume level set by participant (right),16525,-0.0044151379945466,0.0212827505712647,-0.0461293291142255,0.0372990531251323,0.835659844633644
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4288.Time to answer,17066,0.000206982274028969,0.00599188905838017,-0.0115371202803962,0.0119510848284541,0.972443965825242
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4290.Duration screen displayed,17066,0.00940452154902368,0.00548618439089801,-0.00134839985713643,0.0201574429551838,0.0865066840036064
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X46.Hand grip strength (left),50838,-0.0440068087053783,0.00423781580962506,-0.0523129276922434,-0.0357006897185132,3.09769744317959e-25
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X47.Hand grip strength (right),50845,-0.047670360809365,0.00419983436311052,-0.0559020361610616,-0.0394386854576683,8.00713072941207e-30
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X48.Waist circumference,50984,-0.100070131360109,0.00652946319096222,-0.112867879214395,-0.0872723835058235,6.73541528829911e-53
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X4803.Tinnitus,16757,0.0355346046244921,0.025252485147758,-0.0139602662651136,0.0850294755140978,0.159394787022849
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4825.Noisy workplace,16974,-0.00708559618399955,0.0286657764110936,-0.0632705179497429,0.0490993255817438,0.804772196677131
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,16870,-0.0432327529882905,0.0360870511139013,-0.113963373171537,0.0274978671949562,0.230928839217325
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X49.Hip circumference,50975,0.00211404113743529,0.00523652535528365,-0.00814954855892066,0.0123776308337912,0.686427189454507
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X50.Standing height,50931,-0.0179727510230337,0.0041571896540027,-0.026120842744879,-0.00982465930118843,1.54008578796034e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X5057.Number of older siblings,14973,0.0291253404040534,0.0229483352797704,-0.0158533967442965,0.0741040775524034,0.204400159173814
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X51.Seated height,50704,-0.0136645112761651,0.00386807919579329,-0.0212459464999199,-0.00608307605241023,0.000411805932057013
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5181.Ever had eye surgery,11502,-0.0696428191329386,0.051267671514698,-0.170127455301747,0.0308418170358695,0.174358436557013
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),11472,-0.0116473960332993,0.00642342122471716,-0.0242373016337449,0.000942509567146354,0.0698163641057477
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),11470,-0.0150105744683918,0.00647415422113365,-0.0276999167418137,-0.00232123219496983,0.0204375965940546
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),11343,-0.0104656975344046,0.00651226974751341,-0.0232297462395308,0.00229835117072172,0.108066066547315
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),11340,-0.00932969431307636,0.00654445091679933,-0.0221568181100031,0.00349742948385033,0.15401470067217
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",11431,0.0234529097757508,0.0266975221957983,-0.028874233728014,0.0757800532795155,0.379708470568413
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),11431,-0.192778957870551,0.182452112502291,-0.550385098375041,0.164827182633939,0.290716401275099
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5201.logMAR, final (right)",11321,0.00723935359534043,0.00653432209598986,-0.0055679177127997,0.0200466249034806,0.267930016590839
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5202.Number of rounds to result (right),11431,-0.00960675610183197,0.0248144045705887,-0.0582429890601858,0.0390294768565219,0.698656581847923
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",11426,0.0659091960187513,0.0266319653186368,0.0137105439942232,0.11810784804328,0.0133449292809765
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),11426,-0.305627318359191,0.165200289516205,-0.629419885810952,0.0181652490925696,0.0643334693827249
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5208.logMAR, final (left)",11317,0.00880502028767119,0.00653888618355873,-0.00401119663210392,0.0216212372074463,0.178148111825244
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5209.Number of rounds to result (left),11420,0.00188695832102429,0.0249001005485873,-0.0469172387542068,0.0506911553962554,0.939594541334349
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",10929,-0.0301552541537566,0.00648023221384906,-0.0428565092929008,-0.0174539990146125,3.30313591782931e-06
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",10929,-0.0374679335971913,0.00644563392324768,-0.0501013760867568,-0.0248344911076259,6.31131899897873e-09
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),10929,-0.000402451257248892,0.00654147948804333,-0.0132237510538138,0.012418848539316,0.950943846744455
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),10929,-0.0196947032778794,0.00649889422252306,-0.0324325359540246,-0.00695687060173422,0.00244745432787577
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",10899,-0.0388625413677664,0.00648403341011166,-0.0515712468515852,-0.0261538358839475,2.11783307161845e-09
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",10899,-0.0379288140936455,0.00643211697511233,-0.0505357633648656,-0.0253218648224253,3.81666920339494e-09
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),10899,0.00695873442316649,0.00657773439927152,-0.0059336249994057,0.0198510938457387,0.290114169645173
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),10899,-0.0154508212206088,0.00650919938277044,-0.0282088520108388,-0.0026927904303787,0.0176285840104696
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11420,0.00552192337469499,0.119190927236707,-0.228092294009251,0.239136140758641,0.963049325369219
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",50827,0.0247003392442167,0.0170476072233414,-0.00871297091353248,0.0581136494019658,0.147370680370371
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",50827,0.0210046635882527,0.0185009440595616,-0.0152571867684881,0.0572665139449935,0.256242731606402
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",50827,0.0615075042488044,0.0175891229882192,0.0270328231918948,0.095982185305714,0.000471089864469822
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",50827,0.0199404886709021,0.00753196901473364,0.00517782940202412,0.03470314793978,0.00811270988421366
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",50827,-0.0287777968124613,0.00693036513122689,-0.042361312469666,-0.0151942811552566,3.29511943248157e-05
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",22966,-0.0174656991402419,0.00878070435552328,-0.0346758796770675,-0.000255518603416278,0.0467020159853377
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",22966,-0.00501179122893018,0.0238849309411831,-0.051826255873649,0.0418026734157887,0.833801691674052
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",22966,0.0129058265255545,0.017071508444813,-0.020554330026279,0.0463659830773881,0.449665167617524
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",22966,-0.0250909939079225,0.0103914707874467,-0.045458276651318,-0.00472371116452688,0.0157613136063176
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,50981,0.0025646932910796,0.0116067565900415,-0.0201845496254018,0.025313936207561,0.825120146427536
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,50981,-0.0223724158141527,0.0149038257520011,-0.0515839142880748,0.00683908265976937,0.133330983508117
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),50981,-0.0282318774593451,0.0114498918908092,-0.0506736655653312,-0.00579008935335902,0.0136782531604068
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',50981,0.0134306361509138,0.0187921083799691,-0.0234018962738256,0.0502631685756532,0.474800464206048
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),50981,-0.0197395402358841,0.0454454744047308,-0.108812670069156,0.0693335895973883,0.664031371339144
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),50981,-0.0227162927792664,0.0317754960377755,-0.0849962650133064,0.0395636794547735,0.474674293106552
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,50981,0.0335946995816542,0.0500305299010056,-0.0644651390243168,0.131654538187625,0.501915301846203
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,50826,0.0160445580739151,0.00962552074491645,-0.00282146258612115,0.0349105787339513,0.0955450502833043
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,50826,0.0413416844206079,0.01645088960082,0.00909794080300081,0.073585428038215,0.0119727673915879
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,50826,-0.00951233692641185,0.00863081276337159,-0.0264287299426202,0.00740405608979647,0.27040739460931
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,50826,0.0335381217510613,0.0144910883126887,0.00513558865819136,0.0619406548439312,0.0206499583119634
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,50826,0.0185580877839849,0.0143685438646372,-0.00960425819070406,0.0467204337586739,0.196509379463413
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,50826,0.0134426469944084,0.00806634364535524,-0.00236738655048786,0.0292526805393047,0.0956179269487748
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,15806,0.139479321367017,0.0192318237201649,0.101784946875494,0.17717369585854,4.28045022923575e-13
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,15806,0.0883421119459949,0.016531254451849,0.0559408532203708,0.120743370671619,9.22077270160367e-08
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,15806,0.157504770005098,0.0228702098560344,0.11267915868727,0.202330381322925,5.91735883178205e-12
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,15806,-0.118736480221051,0.0182181211613859,-0.154443997697368,-0.0830289627447351,7.36577747384172e-11
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,50767,0.0315164322845659,0.0245957459903645,-0.0166912298565485,0.0797240944256802,0.200067003534116
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,50767,-0.00108702784833912,0.0360712837639546,-0.0717867440256901,0.0696126883290119,0.975959070100887
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,50767,0.204188123685614,0.0644208630876287,0.0779232320338618,0.330453015337366,0.00152741520703617
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,50767,0.0871559015485234,0.0623357189607356,-0.0350221076145184,0.209333910711565,0.162068280493072
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,50767,0.0200178813590551,0.0212117668315964,-0.0215571816308739,0.0615929443489841,0.345319345371805
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,50767,0.0875684536535044,0.028364221606899,0.0319745793039824,0.143162328003026,0.00202102259968232
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,50767,0.0104981095623897,0.0131049822331345,-0.015187655614554,0.0361838747393333,0.423090391604196
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16457,0.0360634578122079,0.0209411066089913,-0.00498111114141505,0.0771080267658309,0.0850634809956431
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16457,0.0141082978351779,0.0225599283499256,-0.0301091617306763,0.0583257574010322,0.531737058455555
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16457,0.0585758280868119,0.0303602548835691,-0.000930271484983591,0.118081927658607,0.0537035076708834
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16457,0.00238776423410309,0.0107453034952824,-0.0186730306166505,0.0234485590848567,0.824149522519373
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",23118,0.0772971012414912,0.00990525908637273,0.0578827934322007,0.0967114090507818,6.26854060365914e-15
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",23118,-0.0498990742365287,0.00966886007556552,-0.0688500399846371,-0.0309481084884203,2.4792784606986e-07
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",23118,-0.00403771820949387,0.00884278833384755,-0.0213695833438351,0.0132941469248473,0.647954656036784
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",23119,-0.030222569740709,0.0209643665000219,-0.071312728080752,0.0108675885993341,0.149424237251864
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",23119,-0.0103505370357963,0.0125187729471698,-0.034887332012249,0.0141862579406564,0.408358263545321
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",23119,0.0418589781586095,0.016907948757778,0.00871939859336459,0.0749985577238544,0.0133047061406856
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,50826,0.042959039020577,0.0202211939702768,0.0033254988388345,0.0825925792023195,0.0336368368748449
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,50826,0.00841392697630151,0.0142414882083383,-0.0194993899120416,0.0363272438646446,0.554654439894527
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,50826,0.0281896037518722,0.0391418380731284,-0.0485283988714595,0.104907606375204,0.471410650454314
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,50826,0.0578059269016628,0.0145675087013797,0.0292536098469587,0.086358243956367,7.25349104500536e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,50826,-0.00341336318131671,0.0166423081170569,-0.0360322870907482,0.0292055607281148,0.837493607444529
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),50826,0.0732189710587034,0.0191267791810989,0.0357304838637496,0.110707458253657,0.000129297942322715
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,50826,-0.00918637463412837,0.00627259230968994,-0.0214806555611207,0.00310790629286392,0.143056466395222
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,9881,0.0875325300362031,0.0180975985035328,0.0520612369692788,0.123003823103127,1.34013439625164e-06
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,9881,0.0699527760200482,0.0223862956286796,0.0260756365878362,0.11382991545226,0.00178439721577141
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,9881,-0.0475107146170537,0.0160089494068871,-0.0788882554545523,-0.016133173779555,0.00300698901088631
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,9881,-0.00996199629459242,0.0143131499610989,-0.0380157702183463,0.0180917776291614,0.486443301227867
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51056,0.0165140633620162,0.0073350456422397,0.00213737390322638,0.030890752820806,0.0243649528626119
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51056,0.042423469196348,0.0211721957162784,0.00092596559244229,0.0839209728002537,0.0451037319595243
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51056,0.000876284826660538,0.00686222810846263,-0.0125736822659262,0.0143262519192473,0.898389396082466
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51056,-0.00167590036409338,0.00663851627898795,-0.0146873922709098,0.011335591542723,0.800693466682017
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51056,0.0204096325938312,0.0102762007591136,0.000268279105968515,0.040550986081694,0.0470268020380104
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51056,0.0197836081528306,0.0091768346752679,0.00179701218930547,0.0377702041163556,0.0311023438145722
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51056,-0.0128409828911125,0.00714365838067344,-0.0268425533172325,0.00116058753500742,0.0722564813667536
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51056,0.0606317663584395,0.0209949346261086,0.0194816944912667,0.101781838225612,0.00387956994482268
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,35313,-0.0131288180621867,0.00721912784108911,-0.0272783086307214,0.00102067250634792,0.0689785756837761
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,35313,-0.0977263484283127,0.00752100460796234,-0.112467517459919,-0.0829851793967065,1.62658818831708e-38
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,35313,0.0812318218373233,0.00848635466442884,0.0645985666950428,0.0978650769796039,1.11357705762548e-21
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,35314,0.041130219606064,0.0116277692728224,0.0183397918313321,0.0639206473807959,0.000404849330785375
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,35314,0.0361170450552411,0.00762543235600878,0.0211711976374639,0.0510628924730183,2.18400117089181e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,50585,-0.0291235759925451,0.0073960476786965,-0.0436198294427902,-0.0146273225422999,8.23691532238195e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,50585,-0.00677234633162277,0.00588637309055283,-0.0183096375891063,0.00476494492586078,0.249938253191753
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,50585,0.0229589611226992,0.00652860987501168,0.0101628857676763,0.0357550364777221,0.000437380731160921
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,50585,-0.000983886387810343,0.0118179307700424,-0.0241470306970934,0.0221792579214727,0.933650149046609
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),50619,-0.0167229160459998,0.00650048777745464,-0.0294638720898109,-0.00398196000218875,0.0100976742130844
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,50619,-0.0102473414456491,0.0101483513087883,-0.0301381100108741,0.00964342711957592,0.312617844522166
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),50826,0.00816132573690968,0.00640712943364674,-0.00439664795303793,0.0207192994268573,0.202744321883905
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,50826,0.0170453105160836,0.00758481682189835,0.00217906954516283,0.0319115514870044,0.0246255404787436
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,50826,0.0687619799903164,0.0114272563358445,0.0463645575720612,0.0911594024085716,1.78487857483899e-09
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,50826,0.0265907253762243,0.0145055700155377,-0.00184019185422969,0.0550216426066782,0.0667877571659874
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,50826,0.0859062482390342,0.0158441859504761,0.054851643776101,0.116960852701967,5.92232106296532e-08
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,50826,0.0176008665653771,0.0189178673454862,-0.0194781534317758,0.0546798865625301,0.35217711725404
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",28912,-0.0182736802129107,0.00399231820265878,-0.0260986238901219,-0.0104487365356995,4.73177949438782e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,49946,-0.0165234598035214,0.0125863040803826,-0.0411926158010714,0.00814569619402854,0.189252104885181
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X874.Duration of walks,43254,-0.0059980267431027,0.00314914290284868,-0.0121703468326861,0.000174293346480702,0.0568317274463428
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,48275,-0.0279825703358546,0.0122572229472465,-0.0520067273124576,-0.00395841335925151,0.0224379151348761
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X894.Duration of moderate activity,37408,0.00495513130567872,0.014806926977222,-0.0240664455696764,0.0339767081810339,0.737891346689605
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,10684,0.00949209959423032,0.00670677697625826,-0.00365318327923586,0.0226373824676965,0.157009821228535
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,48201,-0.0326120029009865,0.0125486793009193,-0.0572074143307883,-0.00801659147118458,0.00935680013822061
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X914.Duration of vigorous activity,26993,0.00734060096509963,0.00394510462946693,-0.000391804108655539,0.0150730060388548,0.0627994028051975
